381 results on '"Christer Nilsson"'
Search Results
2. Structural and microstructural thalamocortical network disruption in sporadic behavioural variant frontotemporal dementia
- Author
-
David Jakabek, Brian D. Power, Nicola Spotorno, Matthew D. Macfarlane, Mark Walterfang, Dennis Velakoulis, Christer Nilsson, Maria Landqvist Waldö, Jimmy Lätt, Markus Nilsson, Danielle van Westen, Olof Lindberg, Jeffrey C.L. Looi, and Alexander F. Santillo
- Subjects
Behavioural variant frontotemporal dementia ,MRI ,Partial least squares ,Shape analysis ,Diffusion ,Computer applications to medicine. Medical informatics ,R858-859.7 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Background: Using multi-block methods we combined multimodal neuroimaging metrics of thalamic morphology, thalamic white matter tract diffusion metrics, and cortical thickness to examine changes in behavioural variant frontotemporal dementia. (bvFTD). Method: Twenty-three patients with sporadic bvFTD and 24 healthy controls underwent structural and diffusion MRI scans. Clinical severity was assessed using the Clinical Dementia Rating scale and behavioural severity using the Frontal Behaviour Inventory by patient caregivers. Thalamic volumes were manually segmented. Anterior and posterior thalamic radiation fractional anisotropy and mean diffusivity were extracted using Tract-Based Spatial Statistics. Finally, cortical thickness was assessed using Freesurfer. We used shape analyses, diffusion measures, and cortical thickness as features in sparse multi-block partial least squares (PLS) discriminatory analyses to classify participants within bvFTD or healthy control groups. Sparsity was tuned with five-fold cross-validation repeated 10 times. Final model fit was assessed using permutation testing. Additionally, sparse multi-block PLS was used to examine associations between imaging features and measures of dementia severity. Results: Bilateral anterior-dorsal thalamic atrophy, reduction in mean diffusivity of thalamic projections, and frontotemporal cortical thinning, were the main features predicting bvFTD group membership. The model had a sensitivity of 96%, specificity of 68%, and was statistically significant using permutation testing (p = 0.012). For measures of dementia severity, we found similar involvement of regional thalamic and cortical areas as in discrimination analyses, although more extensive thalamo-cortical white matter metric changes. Conclusions: Using multimodal neuroimaging, we demonstrate combined structural network dysfunction of anterior cortical regions, cortical-thalamic projections, and anterior thalamic regions in sporadic bvFTD.
- Published
- 2023
- Full Text
- View/download PDF
3. Co-occurrence of CLCN2-related leukoencephalopathy and SPG56
- Author
-
Wejdan Almasoudi, Christer Nilsson, Ulrika Kjellström, Kevin Sandeman, and Andreas Puschmann
- Subjects
CYP2U1 ,SPG56 ,Hereditary spastic paraplegia ,CLCN2 ,Leukoencephalopathy ,Male infertility ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Family Report: Two rare autosomal recessive neurological disorders, leukoencephalopathy with ataxia and spastic paraplegia 56 (SPG56), were found in members of the same family. Two siblings presented with spastic paraplegia, cognitive impairment, bladder and bowel dysfunction and gait ataxia; their consanguineous parents were unaffected. Ophthalmological examination revealed chorioretinopathy. Brain MRI showed T2 hyperintensities and T1 hypointensities in the internal capsules, cerebral peduncles, pyramidal tracts and middle cerebellar peduncles. Both affected siblings were homozygous for CYP2U1 c.947A > T p.(Asp316Val), a known cause for SPG56. However, they were also homozygous for the novel variant CLCN2 c.607G > T, p.(Gly203Cys), classified as a variant of unknown significance. Testing of additional family members revealed homozygosity for both variants in an additional brother, whom we initially considered unaffected. Both male CLCN2 carriers were infertile, and review of the literature revealed one reported case with azoospermia, however the brother had no overt signs of SPG56. His testicular biopsy revealed incomplete maturation arrest in spermatogenesis; clinically we found mild memory impairment and hand tremor and MRI showed similar changes as his siblings. We consider CLCN2 c.607G > T pathogenic because of the neuroradiological and clinical findings, including azoospermia. Conclusion: Considerable workup may be required to determine the pathogenicity of novel variants, and to unambiguously associate phenotype with genotype. In very rare disorders, highly specific clinical or biomarker combinations provide sufficient evidence for a variant’s pathogenicity. Phenotypic variation of monogenic disorders described in the literature may be attributed to a second co-occurring monogenic disorder, especially in consanguineous families. SPG56 may have reduced penetrance.
- Published
- 2023
- Full Text
- View/download PDF
4. Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications
- Author
-
Christer Nilsson, Fredrika Linde, Erik Hulegårdh, Hege Garelius, Vladimir Lazarevic, Petar Antunovic, Jörg Cammenga, Stefan Deneberg, Anna Eriksson, Martin Jädersten, Cecilia Kämpe Björkvall, Lars Möllgård, Lovisa Wennström, Emma Ölander, Martin Höglund, Gunnar Juliusson, and Sören Lehmann
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
Studies of therapy-related AML (t-AML) are usually performed in selected cohorts and reliable incidence rates are lacking. In this study, we characterized, defined the incidence over time and studied prognostic implications in all t-AML patients diagnosed in Sweden between 1997 and 2015. Data were retrieved from nationwide population-based registries. In total, 6,779 AML patients were included in the study, of whom 686 (10%) had t-AML. The median age for t-AML was 71 years and 392 (57%) patients were females. During the study period, the incidence of t-AML almost doubled with a yearly increase in t-AML of 4.5% (95% confidence interval: 2.8%-6.2%), which contributed significantly to the general increase in AML incidence over the study period. t-AML solidly constituted over 10% of all AML cases during the later period of the study. Primary diagnoses with the largest increase in incidence and decrease in mortality rate during the study period (i.e., breast and prostate cancer) contributed significantly to the increased incidence of t-AML. In multivariable analysis, t-AML was associated with poorer outcome in cytogenetically intermediate- and adverse-risk cases but t-AML had no significant impact on outcome in favorable-risk AML, including core binding leukemias, acute promyelocytic leukemia and AML with mutated NPM1 without FLT3-ITD. We conclude that there is a strong increase in incidence in t-AML over time and that t-AML constitutes a successively larger proportion of the AML cases. Furthermore, we conclude that t-AML confers a poor prognosis in cytogenetically intermediate- and adverse-risk, but not in favorable-risk AML.
- Published
- 2022
- Full Text
- View/download PDF
5. Prevalence of dementia diagnoses not otherwise specified in eight European countries: a cross-sectional cohort study
- Author
-
Connie Lethin, Ingalill Rahm Hallberg, Anna Renom Guiteras, Hilde Verbeek, Kai Saks, Minna Stolt, Adelaida Zabalegui, Maria Soto-Martin, and Christer Nilsson
- Subjects
Dementia ,Diagnosis ,Geriatrics ,Home care ,Nursing homes ,Ordinary housing ,RC952-954.6 - Abstract
Abstract Background Dementia is a syndrome, with a wide range of symptoms. It is important to have a timely diagnosis during the disease course to reduce the risk of medication errors, enable future care planning for the patient and their relatives thereby optimizing quality of life (QoL). For this reason, it is important to avoid a diagnosis of dementia not otherwise specified (DNOS) and instead obtain a diagnosis that reflects the underlying pathology. The aim of this study was to investigate the prevalence and associated factors of DNOS in persons with dementia living at home or in a nursing home. Methods This is a cross-sectional cohort study performed in eight European countries. Persons with dementia aged ≥65 years living at home (n = 1223) or in a nursing home (n = 790) were included. Data were collected through personal interviews with questionnaires based on standardised instruments. Specific factors investigated were sociodemographic factors, cognitive function, and mental health, physical health, QoL, resource utilization and medication. Bivariate and backward stepwise multivariate regression analyses were performed. Results The prevalence of DNOS in the eight participating European countries was 16% (range 1–30%) in persons living at home and 21% (range 1–43%) in persons living in a nursing home. These people are more often older compared to those with a specific dementia diagnosis. In both persons living at home and persons living in a nursing home, DNOS was associated with more severe neuropsychiatric symptoms and less use of anti-dementia medication. In addition, persons with DNOS living at home had more symptoms of depression and less use of antidepressant medication. Conclusions The prevalence of DNOS diagnosis is common and seems to vary between European countries. People with DNOS are more often older with more severe neuropsychiatric symptoms and receive fewer anti-dementia medication, anxiolytics and antidepressants. This would support the suggestion that a proper and specific diagnosis of dementia could help the management of their disease.
- Published
- 2019
- Full Text
- View/download PDF
6. CSF placental growth factor – a novel candidate biomarker of frontotemporal dementia
- Author
-
Oskar Hansson, Alexander F. Santillo, Lieke H. Meeter, Karin Nilsson, Maria Landqvist Waldö, Christer Nilsson, Kaj Blennow, John C. vanSwieten, and Shorena Janelidze
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Objective Diagnosis of frontotemporal dementia (FTD) is complicated by the overlap of clinical symptoms with other dementia disorders. Development of robust fluid biomarkers is critical to improve the diagnostic work‐up of FTD. Methods CSF concentrations of placental growth factor (PlGF) were measured in the discovery cohort including patients with FTD (n = 27), Alzheimer disease (AD) dementia (n = 75), DLB or PDD (n = 47), subcortical vascular dementia (VaD, n = 33), mild cognitive impairment that later converted to AD (MCI‐AD, n = 34), stable MCI (sMCI, n = 62), and 50 cognitively healthy controls from the Swedish BioFINDER study. For validation, CSF PlGF was measured in additional independent cohort of FTD patients (n = 22) and controls (n = 18) from the Netherlands. Results In the discovery cohort, MCI, MCI‐AD, AD dementia, DLB‐PDD, VaD, and FTD patients all showed increased CSF levels of PlGF compared with controls (sMCI P = 0.019; MCI‐AD P = 0.005; AD dementia, DLB‐PDD, VaD, and FTD all P
- Published
- 2019
- Full Text
- View/download PDF
7. Functional Diversity of Riparian Woody Vegetation Is Less Affected by River Regulation in the Mediterranean Than Boreal Region
- Author
-
Ivana Lozanovska, María Dolores Bejarano, Maria João Martins, Christer Nilsson, Maria Teresa Ferreira, and Francisca C. Aguiar
- Subjects
functional diversity ,functional traits ,functional richness ,functional redundancy ,riparian woody vegetation ,streamflow regulation ,Plant culture ,SB1-1110 - Abstract
River regulation may filter out riparian plants often resulting in reduced functional diversity, i.e., in the range of functions that organisms have in communities and ecosystems. There is, however, little empirical evidence about the magnitude of such reductions in different regions. We investigated the functional diversity patterns of riparian woody vegetation to streamflow regulation in boreal Sweden and Mediterranean Portugal using nine plant functional traits and field data from 109 sampling sites. We evaluated changes in mean plant functional traits as well as in indices of multidimensional functional traits, i.e., functional richness (FRic) and functional redundancy (FRed) within regions and between free-flowing and regulated river reaches. We found that regulation significantly reduced functional diversity in Sweden but not in Portugal. In Sweden, the increased magnitude of variations in water flow and water level in summer, the prolonged duration of extreme hydrological events, the increased frequency of high-water pulses, and the rate of change in water conditions were the likely main drivers of functional diversity change. Small riparian plant species with tiny leaves, poorly lignified stems, and shallow root systems were consistently associated with regulated sites in the boreal region. In Portugal, the similar functional diversity values for free-flowing and regulated rivers likely stem from the smaller streamflow alterations by regulation combined with the species legacy adaptations to the Mediterranean natural hydrological regimes. We conclude that streamflow regulation may reduce the functional diversity of riparian woody vegetation, but the magnitude of these effects will vary depending on the adaptations of the local flora and the patterns of streamflow disturbances. Our study provides insights into functional diversity patterns of riparian woody vegetation affected by regulation in contrasting biomes and encourages further studies of the functional diversity thresholds for maintaining ecosystems.
- Published
- 2020
- Full Text
- View/download PDF
8. Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia.
- Author
-
Nicola Spotorno, Olof Lindberg, Christer Nilsson, Maria Landqvist Waldö, Danielle van Westen, Karin Nilsson, Susanna Vestberg, Elisabet Englund, Henrik Zetterberg, Kaj Blennow, Jimmy Lätt, Nilsson Markus, Wahlund Lars-Olof, and Santillo Alexander
- Subjects
Medicine ,Science - Abstract
Neurofilaments are structural components of neurons and are particularly abundant in highly myelinated axons. The levels of neurofilament light chain (NfL) in both cerebrospinal fluid (CSF) and plasma have been related to degeneration in several neurodegenerative conditions including frontotemporal dementia (FTD) and NfL is currently considered as the most promising diagnostic and prognostic fluid biomarker in FTD. Although the location and function of filaments in the healthy nervous system suggests a link between increased NfL and white matter degeneration, such a claim has not been fully elucidated in vivo, especially in the context of FTD. The present study provides evidence of an association between the plasma levels of NfL and white matter involvement in behavioral variant FTD (bvFTD) by relating plasma concentration of NfL to diffusion tensor imaging (DTI) metrics in a group of 20 bvFTD patients. The results of both voxel-wise and tract specific analysis showed that increased plasma NfL concentration is associated with a reduction in fractional anisotropy (FA) in a widespread set of white matter tracts including the superior longitudinal fasciculus, the fronto-occipital fasciculus the anterior thalamic radiation and the dorsal cingulum bundle. Plasma NfL concentration also correlated with cortical thinning in a portion of the right medial prefrontal cortex and of the right lateral orbitofrontal cortex. These results support the hypothesis that blood NfL levels reflect the global level of neurodegeneration in bvFTD and help to advance our understanding of the association between this blood biomarker for FTD and the disease process.
- Published
- 2020
- Full Text
- View/download PDF
9. Expression levels of long non-coding RNAs are prognostic for AML outcome
- Author
-
Arvind Singh Mer, Johan Lindberg, Christer Nilsson, Daniel Klevebring, Mei Wang, Henrik Grönberg, Soren Lehmann, and Mattias Rantalainen
- Subjects
lncRNA ,Acute myeloid leukemia ,Prognosis ,Molecular subtype ,Diseases of the blood and blood-forming organs ,RC633-647.5 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Long non-coding RNA (lncRNA) expression has been implicated in a range of molecular mechanisms that are central in cancer. However, lncRNA expression has not yet been comprehensively characterized in acute myeloid leukemia (AML). Here, we assess to what extent lncRNA expression is prognostic of AML patient overall survival (OS) and determine if there are indications of lncRNA-based molecular subtypes of AML. Methods We performed RNA sequencing of 274 intensively treated AML patients in a Swedish cohort and quantified lncRNA expression. Univariate and multivariate time-to-event analysis was applied to determine association between individual lncRNAs with OS. Unsupervised statistical learning was applied to ascertain if lncRNA-based molecular subtypes exist and are prognostic. Results Thirty-three individual lncRNAs were found to be associated with OS (adjusted p value
- Published
- 2018
- Full Text
- View/download PDF
10. Cognitive medicine – a new approach in health care science
- Author
-
Anders Wallin, Petronella Kettunen, Per M. Johansson, Ingibjörg H. Jonsdottir, Christer Nilsson, Michael Nilsson, Marie Eckerström, Arto Nordlund, Lars Nyberg, Katharina S. Sunnerhagen, Johan Svensson, Beata Terzis, Lars-Olof Wahlund, and H. Georg Kuhn
- Subjects
Neurocognitive disorders ,Classification of diseases ,Disability ,Rehabilitation ,Mental functions ,Learning and memory ,Psychiatry ,RC435-571 - Abstract
Abstract Background The challenges of today’s society call for more knowledge about how to maintain all aspects of cognitive health, such as speed/attention, memory/learning, visuospatial ability, language, executive capacity and social cognition during the life course. Main text Medical advances have improved treatments of numerous diseases, but the cognitive implications have not been sufficiently addressed. Disability induced by cognitive dysfunction is also a major issue in groups of patients not suffering from Alzheimer’s disease or related disorders. Recent studies indicate that several negative lifestyle factors can contribute to the development of cognitive impairment, but intervention and prevention strategies have not been implemented. Disability due to cognitive failure among the workforce has become a major challenge. Globally, the changing aging pyramid results in increased prevalence of cognitive disorders, and the diversity of cultures influences the expression, manifestation and consequences of cognitive dysfunction. Conclusions Major tasks in the field of cognitive medicine are basic neuroscience research to uncover diverse disease mechanisms, determinations of the prevalence of cognitive dysfunction, health-economical evaluations, and intervention studies. Raising awareness for cognitive medicine as a clinical topic would also highlight the importance of specialized health care units for an integrative approach to the treatment of cognitive dysfunctions.
- Published
- 2018
- Full Text
- View/download PDF
11. Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review
- Author
-
Emil Ygland, Danielle van Westen, Elisabet Englund, Rosa Rademakers, Zbigniew K. Wszolek, Karin Nilsson, Christer Nilsson, Maria Landqvist Waldö, Irina Alafuzoff, Oskar Hansson, Lars Gustafson, and Andreas Puschmann
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Background The MAPT c.1216C > T (p.Arg406Trp; R406W) mutation is a known cause of frontotemporal dementia with Parkinsonism linked to chromosome 17 tau with Alzheimer’s disease-like clinical features. Methods We compiled clinical data from a new Swedish kindred with R406W mutation. Seven family members were followed longitudinally for up to 22 years. Radiological examinations were performed in six family members and neuropathological examinations in three. We systematically reviewed the literature and compiled clinical, radiological, and neuropathological data on 63 previously described R406W heterozygotes and 3 homozygotes. Results For all cases combined, the median age of onset was 56 years and the median disease duration was 13 years. Memory impairment was the most frequent symptom, behavioral disturbance and language impairment were less common, and Parkinsonism was rare. Disease progression was most often slow. The most frequent clinical diagnosis was Alzheimer’s disease. R406W homozygotes had an earlier age at onset and a higher frequency of behavioral symptoms and Parkinsonism than heterozygotes. In the new Swedish kindred, a consistent imaging finding was ventromedial temporal lobe atrophy, which was evident also in early disease stages as a widening of the collateral sulcus with ensuing atrophy of the parahippocampal gyrus. Unlike previously published R406W carriers, all three autopsied patients from the novel family showed neuropathological similarities with progressive supranuclear palsy, with predominant four-repeat (exon 10+) tau isoform (4R) tauopathy and neurofibrillary tangles accentuated in the basal-medial temporal lobe. Amyloid-β pathology was absent. Conclusions Dominance of 4R over three-repeat (exon 10−) tau isoforms contrasts with earlier reports of R406W patients and was not sufficiently explained by the presence of H1/H2 haplotypes in two of the autopsied patients. R406W patients often show a long course of disease with marked memory deficits. Both our neuropathological results and our imaging findings revealed that the ventromedial temporal lobes were extensively affected in the disease. We suggest that this area may represent the point of origin of tau deposition in this disease with relatively isolated tauopathy.
- Published
- 2018
- Full Text
- View/download PDF
12. A New Tool for Assessing Environmental Impacts of Altering Short-Term Flow and Water Level Regimes
- Author
-
María Dolores Bejarano, Jaime H. García-Palacios, Alvaro Sordo-Ward, Luis Garrote, and Christer Nilsson
- Subjects
fluvial ecosystems ,hydropeaking ,InSTHAn tool ,short-term flow regimes ,subdaily flows ,sustainable river management ,Hydraulic engineering ,TC1-978 ,Water supply for domestic and industrial purposes ,TD201-500 - Abstract
The computational tool InSTHAn (indicators of short-term hydrological alteration) was developed to summarize data on subdaily stream flows or water levels into manageable, comprehensive and ecologically meaningful metrics, and to qualify and quantify their deviation from unaltered states. The pronunciation of the acronym refers to the recording interval of input data (i.e., instant). We compared InSTHAn with the tool COSH-Tool in a characterization of the subdaily flow variability of the Colorado River downstream from the Glen Canyon dam, and in an evaluation of the effects of the dam on this variability. Both tools captured the hydropeaking caused by a dam operation, but only InSTHAn quantified the alteration of key flow attributes, highlighting significant increases in the range of within-day flow variations and in their rates of change. This information is vital to evaluate the potential ecological consequences of the hydrological alteration, and whether they may be irreversible, making InSTHAn a key tool for river flow management.
- Published
- 2020
- Full Text
- View/download PDF
13. Grey and White Matter Clinico-Anatomical Correlates of Disinhibition in Neurodegenerative Disease.
- Author
-
Alexander Frizell Santillo, Karl Lundblad, Markus Nilsson, Maria Landqvist Waldö, Danielle van Westen, Jimmy Lätt, Erik Blennow Nordström, Susanna Vestberg, Olof Lindberg, and Christer Nilsson
- Subjects
Medicine ,Science - Abstract
Disinhibition is an important symptom in neurodegenerative diseases. However, the clinico-anatomical underpinnings remain controversial. We explored the anatomical correlates of disinhibition in neurodegenerative disease using the perspective of grey and white matter imaging. Disinhibition was assessed with a neuropsychological test and a caregiver information-based clinical rating scale in 21 patients with prefrontal syndromes due to behavioural variant frontotemporal dementia (n = 12) or progressive supranuclear palsy (n = 9), and healthy controls (n = 25). Cortical thickness was assessed using the Freesurfer software on 3T MRI data. The integrity of selected white matter tracts was determined by the fractional anisotropy (FA) from Diffusion Tensor Imaging. Disinhibition correlated with the cortical thickness of the right parahippocampal gyrus, right orbitofrontal cortex and right insula and the FA of the right uncinate fasciculus and right anterior cingulum. Notably, no relationship was seen with the thickness of ventromedial prefrontal cortex. Our results support an associative model of inhibitory control, distributed in a medial temporal lobe-insular-orbitofrontal network, connected by the intercommunicating white matter tracts. This reconciles some of the divergences among previous studies, but also questions the current conceptualisation of the "prefrontal" syndrome and the central role attributed to the ventromedial prefrontal cortex in inhibitory control.
- Published
- 2016
- Full Text
- View/download PDF
14. Contrasting Responses among Aquatic Organism Groups to Changes in Geomorphic Complexity Along a Gradient of Stream Habitat Restoration: Implications for Restoration Planning and Assessment
- Author
-
Eliza Maher Hasselquist, Lina E. Polvi, Maria Kahlert, Christer Nilsson, Lisa Sandberg, and Brendan G. McKie
- Subjects
bioassessment ,boreal ,bryophyte ,hydromorphology ,riparian ,river ,substrate heterogeneity ,woody debris ,Hydraulic engineering ,TC1-978 ,Water supply for domestic and industrial purposes ,TD201-500 - Abstract
Many stream restoration projects aim to increase geomorphic complexity, assuming that this increases habitat heterogeneity and, thus, biodiversity. However, empirical data supporting these linkages remain scant. Previous assessments of stream restoration suffer from incomplete quantification of habitat complexity, or a narrow focus on only one organism group and/or one restoration measure, limiting learning. Based on a comprehensive quantification of geomorphic complexity in 20 stream reaches in northern Sweden, ranging from streams channelized for timber floating to restored and reference reaches, we investigated responses of macroinvertebrates, diatoms, and macrophytes to multiple geomorphic metrics. Sediment size heterogeneity, which was generally improved in restored sites, favored macroinvertebrate and diatom diversity and macroinvertebrate abundance. In contrast, macrophyte diversity responded to increased variation along the longitudinal stream profile (e.g., step-pools), which was not consistently improved by the restoration. Our analyses highlight the value of learning across multiple restoration projects, both in identifying which aspects of restoration have succeeded, and pinpointing other measures that might be targeted during adaptive management or future restoration. Given our results, a combination of restoration measures targeting not only sediment size heterogeneity, but also features such as step-pools and instream wood, is most likely to benefit benthic biota in streams.
- Published
- 2018
- Full Text
- View/download PDF
15. High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
- Author
-
Mohsen Karimi, Christer Nilsson, Marios Dimitriou, Monika Jansson, Hans Matsson, Per Unneberg, Sören Lehmann, Juha Kere, and Eva Hellström-Lindberg
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2015
- Full Text
- View/download PDF
16. Striatal Atrophy in the Behavioural Variant of Frontotemporal Dementia: Correlation with Diagnosis, Negative Symptoms and Disease Severity.
- Author
-
Matthew D Macfarlane, David Jakabek, Mark Walterfang, Susanna Vestberg, Dennis Velakoulis, Fiona A Wilkes, Christer Nilsson, Danielle van Westen, Jeffrey C L Looi, and Alexander Frizell Santillo
- Subjects
Medicine ,Science - Abstract
Behavioural variant frontotemporal dementia (bvFTD) is associated with changes in dorsal striatal parts of the basal ganglia (caudate nucleus and putamen), related to dysfunction in the cortico-striato-thalamic circuits which help mediate executive and motor functions. We aimed to determine whether the size and shape of striatal structures correlated with diagnosis of bvFTD, and measures of clinical severity, behaviour and cognition.Magnetic resonance imaging scans from 28 patients with bvFTD and 26 healthy controls were manually traced using image analysis software (ITK-SNAP). The resulting 3-D objects underwent volumetric analysis and shape analysis, through spherical harmonic description with point distribution models (SPHARM-PDM). Correlations with size and shape were sought with clinical measures in the bvTFD group, including Frontal Behavioural Inventory, Clinical Dementia Rating for bvFTD, Color Word Interference, Hayling part B and Brixton tests, and Trail-Making Test.Caudate nuclei and putamina were significantly smaller in the bvFTD group compared to controls (left caudate 16% smaller, partial eta squared 0.173, p=0.003; right caudate 11% smaller, partial eta squared 0.103, p=0.023; left putamen 18% smaller, partial eta squared 0.179, p=0.002; right putamen 12% smaller, partial eta squared 0.081, p=0.045), with global shape deflation in the caudate bilaterally but no localised shape change in putamen. In the bvFTD group, shape deflations on the left, corresponding to afferent connections from dorsolateral prefrontal mediofrontal/anterior cingulate and orbitofrontal cortex, correlated with worsening disease severity. Global shape deflation in the putamen correlated with Frontal Behavioural Inventory scores-higher scoring on negative symptoms was associated with the left putamen, while positive symptoms were associated with the right. Other cognitive tests had poor completion rates.Behavioural symptoms and severity of bvFTD are correlated with abnormalities in striatal size and shape. This adds to the promise of imaging the striatum as a biomarker in this disease.
- Published
- 2015
- Full Text
- View/download PDF
17. The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
- Author
-
Malin Wennström, Yulia Surova, Sara Hall, Christer Nilsson, Lennart Minthon, Oskar Hansson, and Henrietta M Nielsen
- Subjects
Medicine ,Science - Abstract
A major difference in the revised diagnostic criteria for Alzheimer's disease (AD) is the incorporation of biomarkers to support a clinical diagnosis and allow the identification of preclinical AD due to AD neuropathological processes. However, AD-specific fluid biomarkers which specifically distinguish clinical AD dementia from other dementia disorders are still missing. Here we aimed to evaluate the disease-specificity of increased YKL-40 levels in cerebrospinal fluid (CSF) from AD patients with mild to moderate dementia (n = 49) versus Parkinson's disease (PD) (n = 61) and dementia with Lewy bodies (DLB) patients (n = 36), and non-demented controls (n = 44). Second we aimed to investigate whether altered YKL-40 levels are associated with CSF levels of other inflammation-associated molecules. When correcting for age, AD patients exhibited 21.3%, 27.7% and 38.8% higher YKL-40 levels compared to non-demented controls (p = 0.0283), DLB (p = 0.0027) and PD patients (p
- Published
- 2015
- Full Text
- View/download PDF
18. Age-related incidence and family history in frontotemporal dementia: data from the Swedish Dementia Registry.
- Author
-
Christer Nilsson, Maria Landqvist Waldö, Karin Nilsson, Alexander Santillo, and Susanna Vestberg
- Subjects
Medicine ,Science - Abstract
OBJECTIVES: Frontotemporal dementia (FTD) is considered to be a mainly early-onset neurodegenerative disorder with a strong hereditary component. The aim of the study was to investigate age-related incidence and family history in FTD compared to other dementia disorders, especially Alzheimer's disease (AD). METHODS: The Swedish Dementia Registry (SveDem) registers all new cases of dementia diagnosed by the participating centres, including data on demographics, diagnosis, and investigations used. Data for the period 2008-2011 were extracted and compared with age-related population data on a regional and national level. RESULTS: There were 20 305 patients registered in SveDem during 2008-2011, whereof 352 received a diagnosis of FTD. Mean age at diagnosis for FTD was 69.6 years and almost 70% of FTD cases were 65 years or older at the time of diagnosis. Both FTD and AD showed an increased incidence with age, which reached a maximum in the age group 80-84 years at 6.04 and 202 cases per 100 000 person-years, respectively. The proportion of cases with a positive family history was significantly lower in FTD than in AD. CONCLUSIONS: Contrary to general opinion within the field, data from SveDem show that the incidence of FTD increases with age, and that the majority of cases are diagnosed after the age of 65 years. In addition, data from SveDem might suggest that the importance of hereditary factors in general is similar in FTD and AD. The recognition of these findings has important consequences for the diagnosis, treatment and care of patients with FTD.
- Published
- 2014
- Full Text
- View/download PDF
19. Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia.
- Author
-
Alexander Frizell Santillo, Johanna Mårtensson, Olof Lindberg, Markus Nilsson, Amir Manzouri, Maria Landqvist Waldö, Danielle van Westen, Lars-Olof Wahlund, Jimmy Lätt, and Christer Nilsson
- Subjects
Medicine ,Science - Abstract
MRI diffusion tensor imaging (DTI) studies of white matter integrity in behavioral variant frontotemporal dementia have consistently shown involvement of frontal and temporal white matter, corresponding to regional loss of cortical volume. Volumetric imaging has a suboptimal sensitivity as a diagnostic tool and thus we wanted to explore if DTI is a better method to discriminate patients and controls than volumetric imaging. We examined the anterior cingulum bundle in 14 patients with behavioral variant frontotemporal dementia and 22 healthy controls using deterministic manual diffusion tensor tractography, and compared DTI parameters with two measures of cortical atrophy, VBM and cortical thickness, of the anterior cingulate cortex (ACC). Statistically significant changes between patients and controls were detected in all DTI parameters, with large effect sizes. ROC-AUC was for the best DTI parameters: 0.92 (fractional anisotropy) to 0.97 (radial diffusivity), 0.82 for the best cortical parameter, VBM of the ACC. Results from the AUC were confirmed with binary logistic regression analysis including demographic variables, but only for fractional anisotropy and mean diffusivity. Ability to classify patient/nonpatient status was significantly better for mean diffusivity vs. VBM (p=0.031), and borderline significant for fractional anisotropy vs. VBM (p=0.062). The results indicate that DTI could offer advantages in comparison with the assessment of cortical volume in differentiating patients with behavioral variant frontotemporal dementia and controls.
- Published
- 2013
- Full Text
- View/download PDF
20. Assessment of global and regional diffusion changes along white matter tracts in parkinsonian disorders by MR tractography.
- Author
-
Yulia Surova, Filip Szczepankiewicz, Jimmy Lätt, Markus Nilsson, Bengt Eriksson, Alexander Leemans, Oskar Hansson, Danielle van Westen, and Christer Nilsson
- Subjects
Medicine ,Science - Abstract
PurposeThe aim of the study was to determine the usefulness of diffusion tensor tractography (DTT) in parkinsonian disorders using a recently developed method for normalization of diffusion data and tract size along white matter tracts. Furthermore, the use of DTT in selected white matter tracts for differential diagnosis was assessed.MethodsWe quantified global and regional diffusion parameters in major white matter tracts in patients with multiple system atrophy (MSA), progressive nuclear palsy (PSP), idiopathic Parkinson's disease (IPD) and healthy controls). Diffusion tensor imaging data sets with whole brain coverage were acquired at 3 T using 48 diffusion encoding directions and a voxel size of 2×2×2 mm(3). DTT of the corpus callosum (CC), cingulum (CG), corticospinal tract (CST) and middle cerebellar peduncles (MCP) was performed using multiple regions of interest. Regional evaluation comprised projection of fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and the apparent area coefficient (AAC) onto a calculated mean tract and extraction of their values along each structure.ResultsThere were significant changes of global DTT parameters in the CST (MSA and PSP), CC (PSP) and CG (PSP). Consistent tract-specific variations in DTT parameters could be seen along each tract in the different patient groups and controls. Regional analysis demonstrated significant changes in the anterior CC (MD, RD and FA), CST (MD) and CG (AAC) of patients with PSP compared to controls. Increased MD in CC and CST, as well as decreased AAC in CG, was correlated with a diagnosis of PSP compared to IPD.ConclusionsDTT can be used for demonstrating disease-specific regional white matter changes in parkinsonian disorders. The anterior portion of the CC was identified as a promising region for detection of neurodegenerative changes in patients with PSP, as well as for differential diagnosis between PSP and IPD.
- Published
- 2013
- Full Text
- View/download PDF
21. Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy.
- Author
-
Malin Wennström, Yulia Surova, Sara Hall, Christer Nilsson, Lennart Minthon, Fredrik Boström, Oskar Hansson, and Henrietta M Nielsen
- Subjects
Medicine ,Science - Abstract
Neurosin is a protease that in vitro degrades α-synuclein, the main constituent of Lewy bodies found in brains of patients with synucleinopathy including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Several studies have reported reduced cerebrospinal fluid (CSF) levels of α-synuclein in synucleinopathy patients and recent data also proposes a significant role of α-synuclein in the pathophysiology of Alzheimer's disease (AD). To investigate potential links between neurosin and its substrate α-synuclein in vivo we used a commercially available sandwich ELISA and an in-house developed direct ELISA to quantify CSF levels of α-synuclein and neurosin in patients diagnosed with DLB, PD and PD dementia (PDD) versus AD patients and non-demented controls. We found that patients with synucleinopathy displayed lower CSF levels of neurosin and α-synuclein compared to controls and AD patients. In contrast, AD patients demonstrated significantly increased CSF α-synuclein but similar neurosin levels compared to non-demented controls. Further, CSF neurosin and α-synuclein concentrations were positively associated in controls, PD and PDD patients and both proteins were highly correlated to CSF levels of phosphorylated tau in all investigated groups. We observed no effect of gender or presence of the apolipoprotein Eε4 allele on neither neurosin or α-synuclein CSF levels. In concordance with the current literature our study demonstrates decreased CSF levels of α-synuclein in synucleinopathy patients versus AD patients and controls. Importantly, decreased α-synuclein levels in patients with synucleinopathy appear linked to low levels of the α-synuclein cleaving enzyme neurosin. In contrast, elevated levels of α-synuclein in AD patients were not related to any altered CSF neurosin levels. Thus, altered CSF levels of α-synuclein and neurosin in patients with synucleinopathy versus AD may not only mirror disease-specific neuropathological mechanisms but may also serve as fit candidates for future biomarker studies aiming at identifying specific markers of synucleinopathy.
- Published
- 2013
- Full Text
- View/download PDF
22. Evaluating the process of ecological restoration
- Author
-
Christer Nilsson, Asa L. Aradottir, Dagmar Hagen, Guðmundur Halldórsson, Kenneth Høegh, Ruth J. Mitchell, Karsten Raulund-Rasmussen, Kristín Svavarsdóttir, Anne Tolvanen, and Scott D. Wilson
- Subjects
ecological restoration ,evaluation ,Northern Hemisphere ,restoration implementation ,restoration monitoring ,restoration planning ,Biology (General) ,QH301-705.5 ,Ecology ,QH540-549.5 - Abstract
We developed a conceptual framework for evaluating the process of ecological restoration and applied it to 10 examples of restoration projects in the northern hemisphere. We identified three major phases, planning, implementation, and monitoring, in the restoration process. We found that evaluation occurred both within and between the three phases, that it included both formal and informal components, and that it often had an impact on the performance of the projects. Most evaluations were short-term and only some parts of them were properly documented. Poor or short-term evaluation of the restoration process creates a risk that inefficient methods will continue to be used, which reduces the efficiency and effectiveness of restoration. To improve the restoration process and to transfer the knowledge to future projects, we argue for more formal, sustained evaluation procedures, involving all relevant stakeholders, and increased and improved documentation and dissemination of the results.
- Published
- 2016
- Full Text
- View/download PDF
23. Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.
- Author
-
Selina Wray, Matthew Self, NINDS Parkinson's Disease iPSC Consortium, NINDS Huntington's Disease iPSC Consortium, NINDS ALS iPSC Consortium, Patrick A Lewis, Jan-Willem Taanman, Natalie S Ryan, Colin J Mahoney, Yuying Liang, Michael J Devine, Una-Marie Sheerin, Henry Houlden, Huw R Morris, Daniel Healy, Jose-Felix Marti-Masso, Elisavet Preza, Suzanne Barker, Margaret Sutherland, Roderick A Corriveau, Michael D'Andrea, Anthony H V Schapira, Ryan J Uitti, Mark Guttman, Grzegorz Opala, Barbara Jasinska-Myga, Andreas Puschmann, Christer Nilsson, Alberto J Espay, Jaroslaw Slawek, Ludwig Gutmann, Bradley F Boeve, Kevin Boylan, A Jon Stoessl, Owen A Ross, Nicholas J Maragakis, Jay Van Gerpen, Melissa Gerstenhaber, Katrina Gwinn, Ted M Dawson, Ole Isacson, Karen S Marder, Lorraine N Clark, Serge E Przedborski, Steven Finkbeiner, Jeffrey D Rothstein, Zbigniew K Wszolek, Martin N Rossor, and John Hardy
- Subjects
Medicine ,Science - Abstract
Our understanding of the molecular mechanisms of many neurological disorders has been greatly enhanced by the discovery of mutations in genes linked to familial forms of these diseases. These have facilitated the generation of cell and animal models that can be used to understand the underlying molecular pathology. Recently, there has been a surge of interest in the use of patient-derived cells, due to the development of induced pluripotent stem cells and their subsequent differentiation into neurons and glia. Access to patient cell lines carrying the relevant mutations is a limiting factor for many centres wishing to pursue this research. We have therefore generated an open-access collection of fibroblast lines from patients carrying mutations linked to neurological disease. These cell lines have been deposited in the National Institute for Neurological Disorders and Stroke (NINDS) Repository at the Coriell Institute for Medical Research and can be requested by any research group for use in in vitro disease modelling. There are currently 71 mutation-defined cell lines available for request from a wide range of neurological disorders and this collection will be continually expanded. This represents a significant resource that will advance the use of patient cells as disease models by the scientific community.
- Published
- 2012
- Full Text
- View/download PDF
24. Future climate change will favour non-specialist mammals in the (sub)arctics.
- Author
-
Anouschka R Hof, Roland Jansson, and Christer Nilsson
- Subjects
Medicine ,Science - Abstract
Arctic and subarctic (i.e., [sub]arctic) ecosystems are predicted to be particularly susceptible to climate change. The area of tundra is expected to decrease and temperate climates will extend further north, affecting species inhabiting northern environments. Consequently, species at high latitudes should be especially susceptible to climate change, likely experiencing significant range contractions. Contrary to these expectations, our modelling of species distributions suggests that predicted climate change up to 2080 will favour most mammals presently inhabiting (sub)arctic Europe. Assuming full dispersal ability, most species will benefit from climate change, except for a few cold-climate specialists. However, most resident species will contract their ranges if they are not able to track their climatic niches, but no species is predicted to go extinct. If climate would change far beyond current predictions, however, species might disappear. The reason for the relative stability of mammalian presence might be that arctic regions have experienced large climatic shifts in the past, filtering out sensitive and range-restricted taxa. We also provide evidence that for most (sub)arctic mammals it is not climate change per se that will threaten them, but possible constraints on their dispersal ability and changes in community composition. Such impacts of future changes in species communities should receive more attention in literature.
- Published
- 2012
- Full Text
- View/download PDF
25. Future changes in the supply of goods and services from natural ecosystems: prospects for the European north
- Author
-
Roland Jansson, Christer Nilsson, E. Carina H. Keskitalo, Tatiana Vlasova, Marja-Liisa Sutinen, Jon Moen, F. Stuart Chapin III, Kari Anne Bråthen, Mar Cabeza, Terry V. Callaghan, Bob van Oort, Halvor Dannevig, Ingrid A. Bay-larsen, Rolf A. Ims, and Paul Eric Aspholm
- Subjects
barents region ,biodiversity ,climate change ,ecosystem services ,forestry ,game species ,outdoor recreation ,reindeer husbandry ,social-ecological systems ,Biology (General) ,QH301-705.5 ,Ecology ,QH540-549.5 - Abstract
Humans depend on services provided by ecosystems, and how services are affected by climate change is increasingly studied. Few studies, however, address changes likely to affect services from seminatural ecosystems. We analyzed ecosystem goods and services in natural and seminatural systems, specifically how they are expected to change as a result of projected climate change during the 21st century. We selected terrestrial and freshwater systems in northernmost Europe, where climate is anticipated to change more than the global average, and identified likely changes in ecosystem services and their societal consequences. We did this by assembling experts from ecology, social science, and cultural geography in workshops, and we also performed a literature review. Results show that most ecosystem services are affected by multiple factors, often acting in opposite directions. Out of 14 services considered, 8 are expected to increase or remain relatively unchanged in supply, and 6 are expected to decrease. Although we do not predict collapse or disappearance of any of the investigated services, the effects of climate change in conjunction with potential economical and societal changes may exceed the adaptive capacity of societies. This may result in societal reorganization and changes in ways that ecosystems are used. Significant uncertainties and knowledge gaps in the forecast make specific conclusions about societal responses to safeguard human well-being questionable. Adapting to changes in ecosystem services will therefore require consideration of uncertainties and complexities in both social and ecological responses. The scenarios presented here provide a framework for future studies exploring such issues.
- Published
- 2015
- Full Text
- View/download PDF
26. Ecological and Social Dimensions of Ecosystem Restoration in the Nordic Countries
- Author
-
Dagmar Hagen, Kristin Svavarsdottir, Christer Nilsson, Anne K. Tolvanen, Karsten Raulund-Rasmussen, Àsa L. Aradòttir, Anna Maria Fosaa, and Gudmundur Halldorsson
- Subjects
economic incentives ,habitats ,land use pressure ,northern Europe ,regional scale ,restoration efforts ,Biology (General) ,QH301-705.5 ,Ecology ,QH540-549.5 - Abstract
An international overview of the extent and type of ecological restoration can offer new perspectives for understanding, planning, and implementation. The Nordic countries, with a great range of natural conditions but historically similar social and political structures, provide an opportunity to compare restoration approaches and efforts across borders. The aim of this study was to explore variation in ecological restoration using the Nordic countries as an example. We used recent national assessments and expert evaluations of ecological restoration. Restoration efforts differed among countries: forest and peatland restoration was most common in Finland, freshwater restoration was most common in Sweden, restoration of natural heathlands and grasslands was most common in Iceland, restoration of natural and semi-cultural heathlands was most common in Norway, and restoration of cultural ecosystems, mainly abandoned agricultural land, was most common in Denmark. Ecological restoration currently does not occur on the Faroe Islands. Economic incentives influence ecological restoration and depend on laws and policies in each country. Our analyses suggest that habitat types determine the methods of ecological restoration, whereas socio-economic drivers are more important for the decisions concerning the timing and location of restoration. To improve the understanding, planning, and implementation of ecological restoration, we advocate increased cooperation and knowledge sharing across disciplines and among countries, both in the Nordic countries and internationally. An obvious advantage of such cooperation is that a wider range of experiences from different habitats and different socio-economic conditions becomes available and thus provides a more solid basis for developing practical solutions for restoration methods and policies.
- Published
- 2013
- Full Text
- View/download PDF
27. Ecological and Social Aspects of Ecological Restoration: New Challenges and Opportunities for Northern Regions
- Author
-
Christer Nilsson and Ása L. Aradóttir
- Subjects
ecological restoration ,northern regions ,policies ,social-ecological systems ,techniques ,Biology (General) ,QH301-705.5 ,Ecology ,QH540-549.5 - Abstract
Interest in ecological restoration has recently intensified as scientists, policymakers, and stakeholders use restoration in management strategies to address and mitigate global climate change and biodiversity loss. Northern ecosystems offer special challenges to restoration managers because of their short growing seasons and long recovery periods. This special feature of Ecology and Society on ecological restoration in northern regions draws together 11 papers based on presentations from the conference "Restoring the North", convened in October 2011 in Selfoss, Iceland. We summarize two themes of this conference: (1) setting objectives and evaluating success in restoration, and (2) legislation, policy, and implementation of restoration. We conclude that northern countries altogether comprise a significant knowledge base and suggest five actions to enhance restoration practices within them: (1) improved documentation of restoration actions, including objectives, measures and results, (2) regular evaluation of restoration progress and outcome, (3) coordination of conservation actions among northern countries, including location of restoration actions to sites where they are most useful in a global context, (4) formation of a common platform to strengthen development of research about ecological, political, social, and technical aspects of ecological restoration, and (5) education of new generations of restoration actors who can work in diverse biogeographic settings and cultures.
- Published
- 2013
- Full Text
- View/download PDF
28. Demonstration Restoration Measures in Tributaries of the Vindel River Catchment
- Author
-
Johanna Gardeström, Daniel Holmqvist, Lina E. Polvi, and Christer Nilsson
- Subjects
boulders ,large wood ,northern Sweden ,restoration ,river ,stream ,timber floating ,Biology (General) ,QH301-705.5 ,Ecology ,QH540-549.5 - Abstract
Some ecological restoration projects include elements of trial and error where new measures are repeatedly tried, evaluated, and modified until satisfactory results are achieved. Thereafter, the resulting methods may be applied on larger scales. A difficult step is judging whether developed "best-practice" methods have become reasonably ecologically functional or whether further experimentation "demonstration" methods can lead to yet better results. Here, we use a stream restoration project as a case study for evaluating methods and abiotic effects and outlining stakeholder support for demonstration restoration measures, rather than only using best-practice methods. Our work was located in the Vindel River system, a free-flowing river that is part of the Natura 2000 network. The river was exploited for timber floating from 1850-1976, and rapids in the main channel and tributaries below timberline were channelized to increase timber transport capacity. Several side channels in multi-channeled rapids were blocked and the flow was concentrated to a single channel from which boulders and large wood were removed. Hence, previously heterogeneous environments were replaced by more homogeneous systems with limited habitat for riverine species. The restoration project strives to alleviate the effects of fragmentation and channelization in affected rapids by returning coarse sediment from channel margins to the main channel. However, only smaller, angular sediment is available given blasting of large boulders, and large (old-growth) wood is largely absent; therefore, original levels of large boulders and large wood in channels cannot be achieved with standard restoration practices. In 10 demonstration sites, we compensated for this by adding large boulders and large wood (i.e., entire trees) from adjacent upland areas to previously best-practice restored reaches and compared their hydraulic characteristics with 10 other best-practice sites. The demonstration sites exhibited significantly reduced and more variable current velocities, and wider channels, but with less variation than pre-restoration. The ecological response to this restoration has not yet been studied, but potential outcomes are discussed.
- Published
- 2013
- Full Text
- View/download PDF
29. Conflicts Associated with Dam Removal in Sweden
- Author
-
Anna G. C. Lejon, Birgitta Malm Renöfält, and Christer Nilsson
- Subjects
controversies ,dam removal ,information ,obstructions ,reservoirs ,rivers ,stakeholder involvement ,Sweden ,Biology (General) ,QH301-705.5 ,Ecology ,QH540-549.5 - Abstract
The increasing number of deteriorating old dams that need renovation or have lost their function make dam removal a viable management option. There are at least four major reasons for dam removal: safety, law and policy, economy, and ecology. Here we discuss 17 Swedish dams that were recently considered for removal. Because dam removal usually causes controversy, dam removal initiatives may succeed, fail, or result in a compromise such as a bypass channel for migrating fish. We identify and discuss three major obstructions to dam removal: funding, cultural-historical values, and threatened species. To facilitate dam removal, the reasons for, and the effects of, dam removal must be carefully explained, and the public and stakeholders must be kept informed. In complicated cases in which compromise solutions may be the most feasible outcome, the integration of the knowledge of different stakeholders is crucial. The involvement of diverse stakeholders increases their willingness to find compromises, thus avoiding conflicts and failures.
- Published
- 2009
- Full Text
- View/download PDF
30. Linking Flow Regime and Water Quality in Rivers: a Challenge to Adaptive Catchment Management
- Author
-
Christer Nilsson and Birgitta Malm. Renöfält
- Subjects
catchment scale ,ecosystem processes ,environmental flows ,flow regime ,rivers ,water quality ,Biology (General) ,QH301-705.5 ,Ecology ,QH540-549.5 - Abstract
Water quality describes the physicochemical characteristics of the water body. These vary naturally with the weather and with the spatiotemporal variation of the water flow, i.e., the flow regime. Worldwide, biota have adapted to the variation in these variables. River channels and their riparian zones contain a rich selection of adapted species and have been able to offer goods and services for sustaining human civilizations. Many human impacts on natural riverine environments have been destructive and present opportunities for rehabilitation. It is a big challenge to satisfy the needs of both humans and nature, without sacrificing one or the other. New ways of thinking, new policies, and institutional commitment are needed to make improvements, both in the ways water flow is modified in rivers by dam operations and direct extractions, and in the ways runoff from adjacent land is affected by land-use practices. Originally, prescribed flows were relatively static, but precepts have been developed to encompass variation, specifically on how water could be shared over the year to become most useful to ecosystems and humans. A key aspect is how allocations of water interact with physicochemical variation of water. An important applied question is how waste releases and discharge can be managed to reduce ecological and sanitary problems that might arise from inappropriate combinations of flow variation and physicochemical characteristics of water. We review knowledge in this field, provide examples on how the flow regime and the water quality can impact ecosystem processes, and conclude that most problems are associated with low-flow conditions. Given that reduced flows represent an escalating problem in an increasing number of rivers worldwide, managers are facing enormous challenges.
- Published
- 2008
- Full Text
- View/download PDF
31. Restoring Riverine Landscapes: The Challenge of Identifying Priorities, Reference States, and Techniques
- Author
-
Christer Nilsson, Roland Jansson, Björn Malmqvist, and Robert J. Naiman
- Subjects
reference conditions ,restoration objectives ,restoration techniques ,river restoration. ,Biology (General) ,QH301-705.5 ,Ecology ,QH540-549.5 - Abstract
This special issue of Ecology and Society on restoring riverine landscapes draws together nine presentations from the Second International Symposium on Riverine Landscapes, convened in August 2004 in Storforsen, Sweden. We summarize three themes related to river restoration: (1) setting priorities, (2) identifying relevant reference conditions, and (3) choosing appropriate techniques. We discuss ways of developing river restoration and provide examples of future needs in sustaining functioning river ecosystems that can support human societies.
- Published
- 2007
- Full Text
- View/download PDF
32. Structural Thalamocortical Network Atrophy in Sporadic Behavioural Variant Frontotemporal Dementia
- Author
-
David Jakabek, Brian D. Power, Nicola Spotorno, Matthew D. Macfarlane, Mark Walterfang, Dennis Velakoulis, Christer Nilsson, Maria Landqvist Waldö, Jimmy Lätt, Markus Nilsson, Danielle van Westen, Olof Lindberg, Jeffrey C. L. Looi, and Alexander F. Santillo
- Abstract
Using multi-block methods we combined multimodal neuroimaging metrics of thalamic morphology, thalamic white matter tract diffusion metrics, and cortical thickness to examine changes in behavioural variant frontotemporal dementia. (bvFTD). Twenty-three patients with sporadic bvFTD and 24 healthy controls underwent structural and diffusion MRI scans. Clinical severity was assessed using the Clinical Dementia Rating scale and behavioural severity using the Frontal Behaviour Inventory by patient caregivers. Thalamic volumes were manually segmented. Anterior and posterior thalamic radiation fractional anisotropy and mean diffusivity were extracted using Tract-Based Spatial Statistics. Finally, cortical thickness was assessed using Freesurfer. We used shape analyses, diffusion measures, and cortical thickness as features in sparse multi-block partial least squares (PLS) discriminatory analyses to classify participants within bvFTD or healthy control groups. Sparsity was tuned with five-fold cross-validation repeated 10 times. Final model fit was assessed using permutation testing. Additionally, sparse multi-block PLS was used to examine associations between imaging features and measures of dementia severity. The main features predicting bvFTD group membership were bilateral anterior-dorsal thalamic atrophy, increase in mean diffusivity of thalamic projections, and frontotemporal cortical thinning. The model had a sensitivity of 96%, specificity of 68%, and was statistically significant using permutation testing (p = 0.012). For measures of dementia severity, we found similar involvement of regional thalamic and cortical areas as in discrimination analyses, although more extensive thalamo-cortical white matter metric changes. Using multimodal neuroimaging, we demonstrate combined structural network dysfunction of anterior cortical regions, cortical-thalamic projections, and anterior thalamic regions in sporadic bvFTD.
- Published
- 2023
33. Pharmacological Medical Treatment of Epilepsy in Patients with Dementia: A Systematic Review
- Author
-
Gunhild Waldemar, Chris Cooper, Christian Sandøe Musaeus, Milica G. Kramberger, Dorota Religa, Ana Verdelho, Kristian Steen Frederiksen, Elka Stefanova, and Christer Nilsson
- Subjects
Pediatrics ,medicine.medical_specialty ,Levetiracetam ,Lamotrigine ,law.invention ,03 medical and health sciences ,Epilepsy ,0302 clinical medicine ,Randomized controlled trial ,Alzheimer Disease ,law ,medicine ,Humans ,Dementia ,Adverse effect ,Vascular dementia ,Aged ,Randomized Controlled Trials as Topic ,030304 developmental biology ,0303 health sciences ,business.industry ,medicine.disease ,3. Good health ,Neurology ,Tolerability ,Anticonvulsants ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Background: Patients with dementia have an increased risk of developing epilepsy, especially in patients with vascular dementia and Alzheimer’s disease. In selecting the optimal anti- epileptic drug (AED), the possible side effects such as drowsiness and worsening of cognitive function should be taken into consideration, together with co-morbidities and type of epilepsy. Objective: The current systematic review investigates the efficacy, tolerability, and changes in cognitive function after administration of AED in patients with dementia and epilepsy. Methods: We searched six databases, including MEDLINE and CENTRAL, checked reference lists, contacted experts, and searched Google Scholar to identify studies reporting randomized trials. Studies identified were independently screened, data extracted, and quality appraised by two researchers. A narrative synthesis was used to report findings. Results: We included one study with 95 patients with Alzheimer’s disease randomized to either levetiracetam, lamotrigine, or phenobarbital. No significant differences were found for efficacy, but patients receiving levetiracetam showed an improvement in mini-mental state examination scores and had fewer adverse events. Conclusion: High-quality evidence in the form of randomized controlled trials to guide clinicians in choosing an AED in patients with dementia and concomitant epilepsy remains scarce. However, levetiracetam has previously been shown to possibly improve cognition in patients with both mild cognitive impairment and Alzheimer’s disease, is better tolerated in the elderly population, and has no clinically relevant interaction with either cholinesterase inhibitors or NMDA receptor antagonists.
- Published
- 2021
34. AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor binding
- Author
-
Sören Lehmann, Huthayfa Mujahed, Stefan Deneberg, Sofia Bengtzen, Anne Neddermeyer, Christer Nilsson, Sophia Miliara, Andreas Lennartsson, Karl Ekwall, and Lina Cordeddu
- Subjects
0301 basic medicine ,CCCTC-Binding Factor ,Immunology ,Biology ,Response Elements ,Biochemistry ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,hemic and lymphatic diseases ,CEBPA ,Humans ,Enhancer ,Transcription factor ,Gene knockdown ,Gene Expression Regulation, Leukemic ,DNA, Neoplasm ,Cell Biology ,Hematology ,DNA Methylation ,Neoplasm Proteins ,Chromatin ,Cell biology ,Leukemia, Myeloid, Acute ,030104 developmental biology ,RUNX1 ,chemistry ,CTCF ,030220 oncology & carcinogenesis ,DNA methylation ,Azacitidine ,K562 Cells - Abstract
CCTC-binding factor (CTCF) is a key regulator of gene expression through organization of the chromatin structure. Still, it is unclear how CTCF binding is perturbed in leukemia or in cancer in general. We studied CTCF binding by chromatin immunoprecipitation sequencing in cells from patients with acute myeloid leukemia (AML) and in normal bone marrow (NBM) in the context of gene expression, DNA methylation, and azacitidine exposure. CTCF binding was increased in AML compared with NBM. Aberrant CTCF binding was enriched for motifs for key myeloid transcription factors such as CEBPA, PU.1, and RUNX1. AML with TET2 mutations was characterized by a particularly strong gain of CTCF binding, highly enriched for gain in promoter regions, while AML in general was enriched for changes at enhancers. There was a strong anticorrelation between CTCF binding and DNA methylation. Gain of CTCF occupancy was associated with increased gene expression; however, the genomic location (promoter vs distal regions) and enrichment of motifs (for repressing vs activating cofactors) were decisive for the gene expression pattern. Knockdown of CTCF in K562 cells caused loss of CTCF binding and transcriptional repression of genes with changed CTCF binding in AML, as well as loss of RUNX1 binding at RUNX1/CTCF-binding sites. In addition, CTCF knockdown caused increased differentiation. Azacitidine exposure caused major changes in CTCF occupancy in AML patient cells, partly by restoring a CTCF-binding pattern similar to NBM. We conclude that AML displays an aberrant increase in CTCF occupancy that targets key genes for AML development and impacts gene expression.
- Published
- 2020
35. Evaluation of restoration approaches on the Inner Mongolian Steppe based on criteria of the Society for Ecological Restoration
- Author
-
Zhenzhu Xu, Feng Zhang, Guangsheng Zhou, and Christer Nilsson
- Subjects
geography ,geography.geographical_feature_category ,Steppe ,Computer science ,Soil Science ,Model system ,04 agricultural and veterinary sciences ,010501 environmental sciences ,Development ,01 natural sciences ,Management tool ,Ecosystem degradation ,040103 agronomy & agriculture ,0401 agriculture, forestry, and fisheries ,Environmental Chemistry ,Environmental planning ,Restoration ecology ,0105 earth and related environmental sciences ,General Environmental Science - Abstract
Ecological restoration is becoming an increasingly common management tool worldwide. However, a challenge still exists on how to effectively monitor restoration outcomes and evaluate restoration success for ecological restoration managers. In this review, the goal is to evaluate whether the research in a degraded area has been sufficient for fostering efficient restoration measures and follow‐up of restoration success based on the Society for Ecological Restoration (SER) criteria. We selected the Inner Mongolian Steppe (IMS) in China as a model system. This area has been the subject of substantial research over the most recent years to understand degradation processes and restoration outcomes. We put together the variables used to assess degradation and restoration needs in the IMS and analyzed restoration results based on SER's nine criteria for evaluating restoration success. We found that the accomplished research in the IMS only partially supplied the data needed for evaluation of restoration success. The available results were sufficient for a proper evaluation of species composition and tentatively supported assessments of another seven criteria but not self‐sustainability. Grazing exclusion led to the fastest and most successful recovery of degraded steppe, but landscape‐scale processes during restoration in the IMS are still incompletely known. Our review supports large‐scale restoration of the IMS and emphasizes the need for long‐time monitoring for a more complete evaluation of the outcome of the IMS restoration following all SER's criteria.
- Published
- 2020
36. Clinical Conditions 'Suggestive of Progressive Supranuclear Palsy'—Diagnostic Performance
- Author
-
Alex Rajput, Günter U. Höglinger, Max Joseph Grimm, Yaroslau Compta, Leslie W. Ferguson, Wassilios G. Meissner, James B. Rowe, Gesine Respondek, John C. van Swieten, Murray Grossman, Claire Troakes, Armin Giese, Maria Stamelou, Sigrun Roeber, Alexander Pantelyat, Ines Piot, David J. Irwin, Ellen Gelpi, Thomas Arzberger, Christer Nilsson, Neurology, Stamelou, Maria [0000-0003-1668-9925], Irwin, David J [0000-0002-5599-5098], Pantelyat, Alexander [0000-0002-6427-7485], Meissner, Wassilios G [0000-0003-2172-7527], Rowe, James B [0000-0001-7216-8679], Höglinger, Günter U [0000-0001-7587-6187], and Apollo - University of Cambridge Repository
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Pediatrics ,clinical diagnostic criteria ,Neurology ,suggestive ,Autopsy ,Disease ,Neuropathology ,behavioral disciplines and activities ,Article ,diagnosis [Supranuclear Palsy, Progressive] ,Progressive supranuclear palsy ,03 medical and health sciences ,0302 clinical medicine ,autopsy ,mental disorders ,Medicine ,Humans ,Certainty level ,National Institute of Neurological Disorders and Stroke (U.S.) ,ddc:610 ,Stroke ,Retrospective Studies ,neuropathology ,Movement Disorders ,business.industry ,progressive supranuclear palsy ,medicine.disease ,eye diseases ,United States ,nervous system diseases ,ddc ,030104 developmental biology ,Cohort ,Neurology (clinical) ,Supranuclear Palsy, Progressive ,business ,030217 neurology & neurosurgery ,early diagnosis - Abstract
BACKGROUND: The Movement Disorder Society diagnostic criteria for progressive supranuclear palsy introduced the diagnostic certainty level "suggestive of progressive supranuclear palsy" for clinical conditions with subtle signs, suggestive of the disease. This category aims at the early identification of patients, in whom the diagnosis may be confirmed as the disease evolves. OBJECTIVE: To assess the diagnostic performance of the defined clinical conditions suggestive of progressive supranuclear palsy in an autopsy-confirmed cohort. METHODS: Diagnostic performance of the criteria was analyzed based on retrospective clinical data of 204 autopsy-confirmed patients with progressive supranuclear palsy and 216 patients with other neurological diseases. RESULTS: The conditions suggestive of progressive supranuclear palsy strongly increased the sensitivity compared to the National Institute of Neurological Disorders and Stroke and Society for Progressive Supranuclear Palsy criteria. Within the first year after symptom onset, 40% of patients with definite progressive supranuclear palsy fulfilled criteria for suggestive of progressive supranuclear palsy. Two-thirds of patients suggestive of progressive supranuclear palsy evolved into probable progressive supranuclear palsy after an average of 3.6 years. Application of the criteria for suggestive of progressive supranuclear palsy reduced the average time to diagnosis from 3.8 to 2.2 years. CONCLUSIONS: Clinical conditions suggestive of progressive supranuclear palsy allow earlier identification of patients likely to evolve into clinically possible or probable progressive supranuclear and to have underlying progressive supranuclear palsy pathology. Further work needs to establish the specificity and positive predictive value of this category in real-life clinical settings, and to develop specific biomarkers that enhance their diagnostic accuracy in early disease stages. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- Published
- 2020
37. Contributors
- Author
-
Knut Ola Aamodt, Skuja Agnija, Briede Agrita, Nuray (Emir) Akbulut, Aydın Akbulut, Margarita Alexevnina, Hans E. Andersen, Nikolas A. Arnaut, Sophie Ayrault, Mikhail Baklanov, Carole Barthélemy, Jürgen Bäthe, Christian Baumgartner, Serdar Bayarı, Horst Behrendt, Jean-Nicolas Beisel, Vitali V. Bekh, François Bertrand, Gilles Billen, Thomas Bittl, Hélène Blanchoud, Jürg Bloesch, Jim Bogen, Alberto Borges, Elena Borovikova, Jean-Paul Bravard, Vanessa Bremerich, John E. Brittain, Sturla Brørs, Catherine Carré, Georges Carrel, Emmanuel Castella, Dubravka Čerba, Régis Cereghino, Grigory Chuiko, F. Comiti, Alexandra Coynel, Béla Csányi, Francis Dauba, Alain Dauta, Grigore Davideanu, François Delmas, Ghislain de Marsily, Jean-Pierre Descy, Doriane Destrieux, Martin Dokulil, Marie-José Dole-Olivier, Alain Dutartre, Svetlana Dvinskikh, Jon Arne Eie, Parele Elga, Arturo Elosegi, Tatiana V. Eremkina, Henri Etcheber, null Euvgeny, Etienne Everbecq, Per Einar Faugli, Maria Joao Feio, Thibaut Feret, Helmut Fischer, Nicolas Flipo, Mathieu Floury, Georg Frank, Nikolai Friberg, Aleksandra Gancarczyk, Josette Garnier, Johnny Gasperi, Yury Gerasimov, Magali Gerino, Gavrilova Ģertrūde, Chris N. Gibbins, Stankūnavičius Gintautas, Gísli M. Gíslason, Rosa Gómez, Paul Gonthier, Manuel A.S. Graça, Iulia Grecu, Cecile Grosbois, B. Gumiero, Sprinǵe Gunta, Justyna Hachoł, Svein Haugland, Thomas Hein, Alan G. Hildrew, Carl.C. Hoffmann, Nils Arne Hvidsten, Kokorīte Ilga, Anna Istomina, Druvietis Ivars, Sonja C. Jähnig, Arne J. Jensen, Jean Joachim, Celia Joaquim-Justo, Dmitry Karabanov, Ioannis Karaouzas, Viktor M. Katolikov, Patrick Kestemont, Alexander Kitaev, Sergey. K. Kochanov, Alexander V. Kokovkin, Ludmila Korneva, Vladimír Kováč, Brian Kronvang, Leonid A. Kudersky, Vyacheslav V. Kuzovlev, Jan Henning L'Abée-Lund, Thibault Lambert, Nicolas Lamouroux, Adrien Latli, Valentina Lazareva, Maria Leitao, Laurence Lestel, Rob S.E.W. Leuven, Boris Levin, Puy Lim, Alexander Litvinov, Nataliya S. Loboda, Zalewski Maciej, B. Maiolini, Florian Malard, Iain A. Malcolm, Łapińska Małgorzata, Björn Malmqvist, Melnik Maria, Schletterer Martin, Kjetil Melvold, Michel Meybeck, Tibor Mikuska, Camille Minaudo, Natalya Mineeva, Florentina Moatar, Cédric Morana, F. Moroni, Jean-Marie Mouchel, Isabel Muñoz, Timo Muotka, Iulian Nichersu, Christer Nilsson, Victor Noskov, Franciszek Nowacki, Alexander Okhapkin, Jón S. Ólafsson, Jean-Michel Olivier, Naciye Nur Özyurt, Karin Pall, Vladimir Papchenkov, Isabel Pardo, Momir Paunović, Morten L. Pedersen, Svetlana Perova, Vegard Pettersen, Hervé Piégay, Lise-Marie Pigneur, Vasily I. Ponomarev, Carmen Postolache, Elena Presnova, Anne Probst, Ekaterina Pryanichnikova, Martin Pusch, Maja Raković, Jean-Pierre Rebillard, Skorupskas Ričardas, Gaumiga Ritma, Christopher T. Robinson, Stéphane Rodrigues, Fleur Roland, Anna M. Romaní, Sergi Sabater, Yalcın Sahin, Svein Jakob Saltveit, José-Miguel Sánchez-Pérez, Leonard Sandin, Cristina Sandu, Sabine Sauvage, Martin Schletterer, Laurent Schmitt, Martin Schneider-Jacoby, Franz Schöll, Matthias Scholten, Elena Seletkova, Pierre Servais, Grigory Shcherbina, Oleksandra O. Shumilova, Galina Shurganova, Boris G. Skakalsky, Nikolaos Th Skoulikidis, Nike Sommerwerk, Yves Souchon, Chris Soulsby, Katharina Stefke, Sonja Stendera, Angelina S. Stenina, Irina Stepanova, Alexander N. Sukhodolov, Lars M. Svendsen, Eric Tabacchi, Evelyne Tales, Doerthe Tetzlaff, Henn Timm, Klement Tockner, Ion Toderaş, Diego Tonolla, Alexander Tsvetkov, Urs Uehlinger, Laurent¸ia Ungureanu, Marin A. Usatii, Philippe Usseglio-Polatera, Gerard Van der Velde, Gisèle Verniers, Philippe Vervier, Irina Voroshilova, Karl Mathias Wantzen, Ewa Wnuk-Gławdel, Christian Wolter, Margarita I. Yarushina, Christiane Zarfl, null Zinov'ev, and Stamatis Zogaris
- Published
- 2022
38. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration
- Author
-
Barbier, Mathieu, Camuzat, Agnès, Hachimi, Khalid El, Guegan, Justine, Rinaldi, Daisy, Lattante, Serena, Houot, Marion, Sánchez-Valle, Raquel, Sabatelli, Mario, Antonell, Anna, Molina-Porcel, Laura, Clot, Fabienne, Couratier, Philippe, van der Ende, Emma, van der Zee, Julie, Manzoni, Claudia, Camu, William, Cazeneuve, Cécile, Sellal, François, Didic, Mira, Golfier, Véronique, Pasquier, Florence, Duyckaerts, Charles, Rossi, Giacomina, Bruni, Amalia C, Alvarez, Victoria, Gómez-Tortosa, Estrella, de Mendonça, Alexandre, Graff, Caroline, Masellis, Mario, Nacmias, Benedetta, Oumoussa, Badreddine Mohand, Jornea, Ludmila, Forlani, Sylvie, Van Deerlin, Viviana, Rohrer, Jonathan D, Gelpi, Ellen, Rademakers, Rosa, Van Swieten, John, Le Guern, Eric, Van Broeckhoven, Christine, Ferrari, Raffaele, Génin, Emmanuelle, Brice, Alexis, Ber, Le, Isabelle Alexis Brice, Sophie, Auriacombe, Serge, Belliard, Anne, Bertrand, Anne, Bissery, Fre ́ de, ́ ric Blanc, Marie-Paule, Boncoeur, Ste, ́ phanie Bombois, Claire Boutoleau-Bretonnie` re, Agne`, s Camuzat, Mathieu, Ceccaldi, Marie, Chupin, Philippe, Couratier, Olivier, Colliot, Vincent, Deramecourt, Mira, Didic, Bruno, Dubois, Charles, Duyckaerts, Fre ́ de, ́ rique Etcharry-Bouyx, Aure, ́ lie Guignebert-Funkiewiez, Maı ̈te, ́ Formaglio, ́ ronique Golfier, Ve, Marie-Odile, Habert, Didier, Hannequin, Lucette, Lacomblez, Julien, Lagarde, ́ raldine Lautrette, Ge, Isabelle Le Ber, Benjamin Le Toullec, Richard, Levy, Marie-Anne, Mackowiak, Bernard-Franc ̧ois Michel, Florence, Pasquier, Thibaud, Lebouvier, Carole Roue, ́ -Jagot, Christel Thauvin- Robinet, Catherine, Thomas-Anterion, Je ́ re, ́ mie Pariente, Franc ̧ois Salachas, Sabrina, Sayah, Franc ̧ois Sellal, Assi-Herve, ́ Oya, Daisy, Rinaldi, Adeline, Rollin-Sillaire, Martine, Vercelletto, David, Wallon, Armelle, Rametti-Lacroux, Raffaele, Ferrari, Hernandez, Dena G., Nalls, Michael A., Rohrer, Jonathan D., Adaikalavan, Ramasamy, Kwok, John B. J., Carol Dobson- Stone, Brooks, William S., Schofield, Peter R., Halliday, Glenda M., Hodges, John R., Olivier, Piguet, Lauren, Bartley, Elizabeth, Thompson, Isabel Herna, ́ ndez, Agustı ́n Ruiz, Merce`, Boada, Barbara, Borroni, Alessandro, Padovani, Carlos, Cruchaga, Cairns, Nigel J., Luisa, Benussi, Giuliano, Binetti, Roberta, Ghidoni, Gianluigi, Forloni, Diego, Albani, Daniela, Galimberti, Chiara, Fenoglio, Maria, Serpente, Elio, Scarpini, ́ n, Jordi Clarimo, Alberto Lleo, ́, Rafael, Blesa, Maria Landqvist Waldo, ̈, Karin, Nilsson, Christer, Nilsson, Mackenzie, Ian R. A., Hsiung, Ging-Yuek R., Mann, David M. A., Jordan, Grafman, Morris, Christopher M., Johannes, Attems, Griffiths, Timothy D., Mckeith, Ian G., Thomas, Alan J., Pietro, Pietrini, Edward, Uey, Wassermann, Eric M., Atik, Baborie, Evelyn, Jaros, Tierney, Michael C., Pau, Pastor, Cristina, Razquin, Sara, Ortega-Cubero, Elena, Alonso, Robert, Perneczky, Janine, Diehl-Schmid, Panagiotis, Alexopoulos, Alexander, Kurz, Rainero, Innocenzo, Rubino, Elisa, Pinessi, Lorenzo, Ekaterina, Rogaeva, Peter St George-Hyslop, Giacomina, Rossi, Fabrizio, Tagliavini, Giorgio, Giaccone, Rowe, James B., Schlachetzki, Johannes C. M., James, Uphill, John, Collinge, Simon, Mead, Adrian, Danek, Van Deerlin, Vivianna M., Murray, Grossman, Trojanowski, John Q., Julie van der Zee, Christine Van Broeckhoven, Cappa, Stefano F., Isabelle, Leber, Alexis, Brice, Benedetta, Nacmias, Sandro, Sorbi, Silvia, Bagnoli, Irene, Piaceri, Nielsen, Jørgen E., Hjermind, Lena E., Matthias, Riemenschneider, Manuel, Mayhaus, Bernd, Ibach, Gilles, Gasparoni, Sabrina, Pichler, Wei, Gu, Rossor, Martin N., Fox, Nick C., Warren, Jason D., Maria Grazia Spillantini, Morris, Huw R., Patrizia, Rizzu, Peter, Heutink, Snowden, Julie S., Sara, Rollinson, Anna, Richardson, Alexander, Gerhard, Bruni, Amalia C., Raffaele, Maletta, Francesca, Frangipane, Chiara, Cupidi, Livia, Bernardi, Maria, Anfossi, Maura, Gallo, Maria Elena Conidi, Nicoletta, Smirne, Rosa, Rademakers, Matt, Baker, Dickson, Dennis W., Graff-Radford, Neill R., Petersen, Ronald C., David, Knopman, Josephs, Keith A., Boeve, Bradley F., Parisi, Joseph E., Seeley, William W., Miller, Bruce L., Karydas, Anna M., Howard, Rosen, van Swieten, John C., Dopper, Elise G. P., Harro, Seelaar, Pijnenburg, Yolande A. L., Philip, Scheltens, Giancarlo, Logroscino, Rosa, Capozzo, Valeria, Novelli, Puca, Annibale A., Massimo, Franceschi, Alfredo, Postiglione, Graziella, Milan, Paolo, Sorrentino, Mark, Kristiansen, Huei-Hsin, Chiang, Caroline, Graff, Adeline, Rollin, Dimitrios, Kapogiannis, Luigi, Ferrucci, Stuart, Pickering-Brown, Singleton, Andrew B., John, Hardy, Parastoo, Momeni., Neurology, Amsterdam Neuroscience - Neurodegeneration, Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma] (Unicatt), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), Centre d'investigation clinique Paris Est [CHU Pitié Salpêtrière] (CIC Paris-Est), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Hôpital Dupuytren [CHU Limoges], Erasmus University Medical Center [Rotterdam] (Erasmus MC), Center for Molecular Neurology (VIB-UAntwerp), University of Antwerp (UA), University College of London [London] (UCL), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Service de Neurologie [Hôpitaux Civils de Colmar], Hôpitaux Civils Colmar, Mécanismes Centraux et Périphériques de la Neurodégénérescence, Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Neurologie, maladies neuro-musculaires [Hôpital de la Timone - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Institut de Neurosciences des Systèmes (INS), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Yves le Foll, Lille Neurosciences & Cognition - U 1172 (LilNCog), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Fondazione IRCCS Istituto Neurologico 'Carlo Besta', Regional Neurogenetic Centre [Lamezia Terme, Italy] (CRN - ASP Catanzaro), Hospital Central de Asturias, Institute of Health Research of Principado de Asturias (ISPA), Fundación Jiménez Díaz, Fundacion Jimenez Diaz [Madrid] (FJD), Faculdade de Medicina [Lisboa], Universidade de Lisboa = University of Lisbon (ULISBOA), Karolinska University Hospital [Stockholm], Sunnybrook Research Institute [Toronto] (SRI), Sunnybrook Health Sciences Centre, Università degli Studi di Firenze = University of Florence (UniFI), Fondazione Don Carlo Gnocchi, Plateforme Post-génomique de la Pitié-Salpêtrière (PASS-P3S), Unité Mixte de Service Production et Analyse de données en Sciences de la vie et en Santé (PASS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Hospital of the University of Pennsylvania (HUP), Perelman School of Medicine, University of Pennsylvania-University of Pennsylvania, Neurodegenerative Brain Diseases group, Department of Molecular Genetics, VIB, Antwerpen, Belgium, Génétique, génomique fonctionnelle et biotechnologies (UMR 1078) (GGB), EFS-Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO), The French clinical and genetic Research network on FTLD/FTLD-ALS and PREVDEMALS, The International Frontotemporal Dementia Genomics Consortium, The European Early Onset Dementia (EU -EOD) Consortium, Brainbank Neuro-CEB Neuropathology Network, and Neurological Tissue Bank of the Biobank Hospital Clinic-IDIBAPS
- Subjects
Adult ,Male ,TDP-43 ,C9orf72 ,SLITRK2 ,amyotrophic lateral sclerosis ,frontotemporal dementia ,Nerve Tissue Proteins ,Settore MED/03 - GENETICA MEDICA ,Polymorphism, Single Nucleotide ,Cohort Studies ,Genes, X-Linked ,80 and over ,Medicine ,Dementia ,Humans ,Allele ,Age of Onset ,Polymorphism ,Aged ,Aged, 80 and over ,biology ,C9orf72 Protein ,business.industry ,Membrane Proteins ,MESH: Frontotemporal Lobar Degeneration / epidemiology ,Frontotemporal Lobar ,Degeneration / genetics ,Genes, X-Linked / genetics ,Genome-Wide Association Study / methods ,Frontotemporal lobar degeneration ,Single Nucleotide ,Middle Aged ,X-Linked ,medicine.disease ,Amyotrophic lateral sclerosis ,Minor allele frequency ,Genes ,Immunology ,Synaptophysin ,biology.protein ,Female ,MESH: Adult ,C9orf72 Protein / genetics ,Frontotemporal Lobar Degeneration / diagnosis ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Human medicine ,Neurology (clinical) ,MESH: Humans ,Membrane Proteins / genetics ,Nerve Tissue Proteins / genetics ,Polymorphism, Single Nucleotide / genetics ,Age of onset ,Frontotemporal Lobar Degeneration ,business ,Frontotemporal dementia ,Genome-Wide Association Study - Abstract
The G4C2-repeat expansion in C9orf72 is the most common cause of frontotemporal dementia and of amyotrophic lateral sclerosis. The variability of age at onset and phenotypic presentations is a hallmark of C9orf72 disease. In this study, we aimed to identify modifying factors of disease onset in C9orf72 carriers using a family-based approach, in pairs of C9orf72 carrier relatives with concordant or discordant age at onset. Linkage and association analyses provided converging evidence for a locus on chromosome Xq27.3. The minor allele A of rs1009776 was associated with an earlier onset (P = 1 × 10−5). The association with onset of dementia was replicated in an independent cohort of unrelated C9orf72 patients (P = 0.009). The protective major allele delayed the onset of dementia from 5 to 13 years on average depending on the cohort considered. The same trend was observed in an independent cohort of C9orf72 patients with extreme deviation of the age at onset (P = 0.055). No association of rs1009776 was detected in GRN patients, suggesting that the effect of rs1009776 was restricted to the onset of dementia due to C9orf72. The minor allele A is associated with a higher SLITRK2 expression based on both expression quantitative trait loci (eQTL) databases and in-house expression studies performed on C9orf72 brain tissues. SLITRK2 encodes for a post-synaptic adhesion protein. We further show that synaptic vesicle glycoprotein 2 and synaptophysin, two synaptic vesicle proteins, were decreased in frontal cortex of C9orf72 patients carrying the minor allele. Upregulation of SLITRK2 might be associated with synaptic dysfunctions and drives adverse effects in C9orf72 patients that could be modulated in those carrying the protective allele. How the modulation of SLITRK2 expression affects synaptic functions and influences the disease onset of dementia in C9orf72 carriers will require further investigations. In summary, this study describes an original approach to detect modifier genes in rare diseases and reinforces rising links between C9orf72 and synaptic dysfunctions that might directly influence the occurrence of first symptoms.
- Published
- 2021
39. [18F]Flortaucipir distinguishes Alzheimer’s disease from progressive supranuclear palsy pathology in a mixed-pathology case
- Author
-
Ruben Smith, Oskar Hansson, Daria Pawlik, Christer Nilsson, and Elisabet Englund
- Subjects
Pathology ,medicine.medical_specialty ,Neurology ,medicine.diagnostic_test ,business.industry ,Magnetic resonance imaging ,Disease ,medicine.disease ,Pathology and Forensic Medicine ,Progressive supranuclear palsy ,Cellular and Molecular Neuroscience ,Supranuclear palsy ,Positron emission tomography ,Correspondence ,medicine ,Neurology (clinical) ,business - Published
- 2020
40. Increasing Synchrony of Annual River‐Flood Peaks and Growing Season in Europe
- Author
-
Christer Nilsson and Thorsten Balke
- Subjects
geography ,geography.geographical_feature_category ,Biogeomorphology ,010504 meteorology & atmospheric sciences ,Flood myth ,Floodplain ,Climate change ,Growing season ,010502 geochemistry & geophysics ,01 natural sciences ,Geophysics ,Disturbance (ecology) ,General Earth and Planetary Sciences ,Environmental science ,Ecosystem ,Physical geography ,0105 earth and related environmental sciences ,Riparian zone - Abstract
In a changing climate, time sensitive ecological interactions such as pollination and predation are vulnerable to temporal mismatch with direct consequences for ecosystem functioning. It is not known if synchrony and asynchrony of ecological and physical processes such as flood disturbance and plant phenology may similarly be affected by climate change. Here, by spatially merging temperature and flood peak data, we show for the first time that in Central and Eastern Europe annual river flood peaks increasingly occur within the thermal growing season. This is due to the combined effect of earlier springs and later flood peaks. Such increased physical‐phenological synchrony may especially impact river biogeomorphology and riparian floodplain ecosystem functioning through uprooting of seedlings and increased hydraulic roughness during major flood events.
- Published
- 2019
41. Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting
- Author
-
Lars Möllgård, Erik Hulegårdh, Gunnar Juliusson, Dick Stockelberg, Ulla Frödin, Martin Höglund, Anders Wahlin, Stig Lenhoff, Sören Lehmann, Mats Brune, Mats Remberger, Hege Garelius, and Christer Nilsson
- Subjects
Adult ,Male ,Oncology ,medicine.medical_specialty ,Time Factors ,Adolescent ,medicine.medical_treatment ,Population ,Disease-Free Survival ,03 medical and health sciences ,0302 clinical medicine ,hemic and lymphatic diseases ,Internal medicine ,medicine ,Humans ,Secondary Acute Myeloid Leukemia ,education ,neoplasms ,Aged ,Retrospective Studies ,Aged, 80 and over ,Transplantation ,Chemotherapy ,education.field_of_study ,Hematology ,business.industry ,Proportional hazards model ,Myelodysplastic syndromes ,Hazard ratio ,Hematopoietic Stem Cell Transplantation ,Middle Aged ,Allografts ,medicine.disease ,Survival Rate ,Leukemia, Myeloid, Acute ,surgical procedures, operative ,030220 oncology & carcinogenesis ,Female ,business ,030215 immunology - Abstract
Secondary AML (s-AML), including AML with an antecedent hematologic disorder (AHD-AML) and therapy-related AML (t-AML), constitutes a large proportion of patients with AML and is considered to confer a dismal prognosis. The role of allogeneic hematopoietic cell transplantation (HCT) in patients with s-AML and the extent to which HCT is performed in these patients has been little studied to date. We used the population-based Swedish AML Registry comprising 3337 intensively treated adult patients over a 17-year period to study the role of HCT within the group of patients with s-AML as well as compared with patients with de novo AML. HCT was performed in 576 patients (22%) with de novo AML, in 74 patients (17%) with AHD-AML, and in 57 patients (20%) with t-AML. At 5 years after diagnosis, there were no survivors among patients with previous myeloproliferative neoplasms who did not undergo HCT, and corresponding survival for patients with antecedent myelodysplastic syndromes and t-AML was and 2% and 4%, respectively. HCT was compared with chemotherapy consolidation in s-AML using 3 models: (1) a 200-day landmark analysis, in which HCT was favorable compared with conventional consolidation (P = .04, log-rank test); (2) a multivariable Cox regression with HCT as a time-dependent variable, in which the hazard ratio for mortality was 0.73 (95% confidence interval, 0.64 to 0.83) for HCT and favored HCT in all subgroups; and (3) a propensity score matching analysis, in which the 5-year overall survival (OS) and relapse-free survival in patients with s-AML in first complete remission (CR1) was 48% and 43%, respectively, for patients undergoing HCT versus 20% and 21%, respectively, for those receiving chemotherapy consolidation (P = .01 and .02, respectively, log-rank test). Our observational data suggest that HCT improves survival and offers the only realistic curative treatment option in patients with s-AML.
- Published
- 2019
42. Prevalence of dementia diagnoses not otherwise specified in eight European countries: a cross-sectional cohort study
- Author
-
Hilde Verbeek, Ingalill Rahm Hallberg, Connie Lethin, Anna Renom Guiteras, Christer Nilsson, Maria Soto-Martin, Kai Saks, Minna Stolt, Adelaida Zabalegui, Health Services Research, RS: CAPHRI - R1 - Ageing and Long-Term Care, and RS: Academische Werkplaats Ouderenzorg
- Subjects
Male ,Gerontology ,SYMPTOMS ,lcsh:Geriatrics ,DISEASE ,Cohort Studies ,Cognition ,0302 clinical medicine ,Quality of life ,Surveys and Questionnaires ,Diagnosis ,Prevalence ,Medicine ,030212 general & internal medicine ,Depression (differential diagnoses) ,Aged, 80 and over ,Geriatrics ,Not Otherwise Specified ,DEPRESSION ,3. Good health ,Europe ,Female ,Independent Living ,Regression analysis ,Research Article ,Cohort study ,Ordinary housing ,medicine.medical_specialty ,Nursing homes ,Home care ,Neurocognitive disorders ,03 medical and health sciences ,PEOPLE ,Humans ,Dementia ,Aged ,business.industry ,MORTALITY ,Public health ,CARE ,medicine.disease ,Mental health ,lcsh:RC952-954.6 ,Cross-Sectional Studies ,Quality of Life ,Geriatrics and Gerontology ,business ,030217 neurology & neurosurgery - Abstract
BACKGROUND: Dementia is a syndrome, with a wide range of symptoms. It is important to have a timely diagnosis during the disease course to reduce the risk of medication errors, enable future care planning for the patient and their relatives thereby optimizing quality of life (QoL). For this reason, it is important to avoid a diagnosis of dementia not otherwise specified (DNOS) and instead obtain a diagnosis that reflects the underlying pathology. The aim of this study was to investigate the prevalence and associated factors of DNOS in persons with dementia living at home or in a nursing home. METHODS: This is a cross-sectional cohort study performed in eight European countries. Persons with dementia aged ≥65 years living at home (n = 1223) or in a nursing home (n = 790) were included. Data were collected through personal interviews with questionnaires based on standardised instruments. Specific factors investigated were sociodemographic factors, cognitive function, and mental health, physical health, QoL, resource utilization and medication. Bivariate and backward stepwise multivariate regression analyses were performed. RESULTS: The prevalence of DNOS in the eight participating European countries was 16% (range 1-30%) in persons living at home and 21% (range 1-43%) in persons living in a nursing home. These people are more often older compared to those with a specific dementia diagnosis. In both persons living at home and persons living in a nursing home, DNOS was associated with more severe neuropsychiatric symptoms and less use of anti-dementia medication. In addition, persons with DNOS living at home had more symptoms of depression and less use of antidepressant medication. CONCLUSIONS: The prevalence of DNOS diagnosis is common and seems to vary between European countries. People with DNOS are more often older with more severe neuropsychiatric symptoms and receive fewer anti-dementia medication, anxiolytics and antidepressants. This would support the suggestion that a proper and specific diagnosis of dementia could help the management of their disease. This study was supported by grants from the Greta and Johan Kocks Foundation and Skåne University Hospitals Foundations in Sweden. The RTPC study was supported by a grant from the European Commission within the 7th Framework Programme (contract number 242153).
- Published
- 2019
43. <scp>CSF</scp> placental growth factor – a novel candidate biomarker of frontotemporal dementia
- Author
-
Oskar Hansson, Karin Nilsson, Alexander Santillo, Shorena Janelidze, Kaj Blennow, Lieke H.H. Meeter, Maria Landqvist Waldö, Christer Nilsson, John C. van Swieten, Neurology, Amsterdam Neuroscience - Neurodegeneration, and Human genetics
- Subjects
Male ,0301 basic medicine ,Placental growth factor ,Oncology ,medicine.medical_specialty ,Neurology ,tau Proteins ,Neurosciences. Biological psychiatry. Neuropsychiatry ,behavioral disciplines and activities ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Alzheimer Disease ,Internal medicine ,mental disorders ,medicine ,Humans ,Dementia ,RC346-429 ,Research Articles ,Aged ,Placenta Growth Factor ,Aged, 80 and over ,Amyloid beta-Peptides ,business.industry ,General Neuroscience ,nutritional and metabolic diseases ,Middle Aged ,medicine.disease ,nervous system diseases ,030104 developmental biology ,Frontotemporal Dementia ,Cohort ,Biomarker (medicine) ,Female ,Neurology. Diseases of the nervous system ,Neurology (clinical) ,Alzheimer's disease ,business ,Biomarkers ,030217 neurology & neurosurgery ,Research Article ,RC321-571 ,Cohort study ,Frontotemporal dementia - Abstract
Objective: Diagnosis of frontotemporal dementia (FTD) is complicated by the overlap of clinical symptoms with other dementia disorders. Development of robust fluid biomarkers is critical to improve the diagnostic work-up of FTD. Methods: CSF concentrations of placental growth factor (PlGF) were measured in the discovery cohort including patients with FTD (n = 27), Alzheimer disease (AD) dementia (n = 75), DLB or PDD (n = 47), subcortical vascular dementia (VaD, n = 33), mild cognitive impairment that later converted to AD (MCI-AD, n = 34), stable MCI (sMCI, n = 62), and 50 cognitively healthy controls from the Swedish BioFINDER study. For validation, CSF PlGF was measured in additional independent cohort of FTD patients (n = 22) and controls (n = 18) from the Netherlands. Results: In the discovery cohort, MCI, MCI-AD, AD dementia, DLB-PDD, VaD, and FTD patients all showed increased CSF levels of PlGF compared with controls (sMCI P = 0.019; MCI-AD P = 0.005; AD dementia, DLB-PDD, VaD, and FTD all P
- Published
- 2019
44. Importance of landscape context for post‐restoration recovery of riparian vegetation
- Author
-
Christer Nilsson, Lina E. Polvi, Francesca Pilotto, Xiaolei Su, and Lovisa Lind
- Subjects
0106 biological sciences ,geography ,geography.geographical_feature_category ,Ecology ,010604 marine biology & hydrobiology ,Ecology (disciplines) ,Context (language use) ,STREAMS ,Aquatic Science ,010603 evolutionary biology ,01 natural sciences ,Floristics ,Species pool ,Plant Dispersal ,Biological sciences ,Riparian zone - Abstract
We tested whether the recovery of riparian vegetation along rapids that have been restored after channelisation for timber floating can be predicted based on floristic and geomorphic characteristic ...
- Published
- 2019
45. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy
- Author
-
David J. Irwin, Kailash P. Bhatia, Sigrun Roeber, Jennifer L. Whitwell, Claire Troakes, Alexander Pantelyat, Günter U. Höglinger, Jan Kassubek, Ines Piot, John C. van Swieten, Thomas Arzberger, Alex Rajput, Angelo Antonini, Leslie W. Ferguson, Werner Poewe, Irene Litvan, Thilo van Eimeren, Max-Joseph Grimm, Carlo Colosimo, Ellen Gelpi, Johannes Levin, Gesine Respondek, Adam L. Boxer, Jean-Christophe Corvol, Wassilios G. Meissner, Lawrence I. Golbe, Huw R. Morris, James B. Rowe, Christer Nilsson, Maria Stamelou, Gregor K. Wenning, Murray Grossman, Wolfgang H. Oertel, Anthony E. Lang, Yaroslau Compta, Keith A. Josephs, Armin Giese, Neurology, Rowe, James [0000-0001-7216-8679], and Apollo - University of Cambridge Repository
- Subjects
Male ,0301 basic medicine ,physiopathology [Cognitive Dysfunction] ,classification [Supranuclear Palsy, Progressive] ,physiopathology [Supranuclear Palsy, Progressive] ,Movement Disorder Society-endorsed PSP Study Group ,diagnosis [Supranuclear Palsy, Progressive] ,Cohort Studies ,Ocular Motility Disorders ,0302 clinical medicine ,pathology [Brain] ,80 and over ,Supranuclear Palsy ,Medicine ,Postural Balance ,Societies, Medical ,Aged, 80 and over ,Pediatric ,screening and diagnosis ,Movement (music) ,Brain ,Middle Aged ,Detection ,physiopathology [Ocular Motility Disorders] ,Neurology ,autopsy ,diversity ,phenotype ,progressive supranuclear palsy ,physiopathology [Parkinsonian Disorders] ,Sensation Disorders ,Female ,Cognitive Sciences ,Supranuclear Palsy, Progressive ,4.2 Evaluation of markers and technologies ,Adult ,medicine.medical_specialty ,physiopathology [Sensation Disorders] ,pathology [Supranuclear Palsy, Progressive] ,Clinical Sciences ,Article ,Progressive supranuclear palsy ,03 medical and health sciences ,Rare Diseases ,Physical medicine and rehabilitation ,Parkinsonian Disorders ,Progressive ,Clinical Research ,Medical ,Humans ,Cognitive Dysfunction ,ddc:610 ,Retrospective Studies ,Aged ,Neurology & Neurosurgery ,business.industry ,Neurosciences ,Human Movement and Sports Sciences ,Perinatal Period - Conditions Originating in Perinatal Period ,medicine.disease ,Brain Disorders ,030104 developmental biology ,Neurology (clinical) ,Societies ,business ,030217 neurology & neurosurgery - Abstract
BACKGROUND: The Movement Disorder Society criteria for progressive supranuclear palsy define diagnostic allocations, stratified by certainty levels and clinical predominance types. We aimed to study the frequency of ambiguous multiple allocations and to develop rules to eliminate them. METHODS: We retrospectively collected standardized clinical data by chart review in a multicenter cohort of autopsy-confirmed patients with progressive supranuclear palsy, to classify them by diagnostic certainty level and predominance type and to identify multiple allocations. RESULTS: Comprehensive data were available from 195 patients. More than one diagnostic allocation occurred in 157 patients (80.5%). On average, 5.4 allocations were possible per patient. We developed four rules for Multiple Allocations eXtinction (MAX). They reduced the number of patients with multiple allocations to 22 (11.3%), and the allocations per patient to 1.1. CONCLUSIONS: The proposed MAX rules help to standardize the application of the Movement Disorder Society criteria for progressive supranuclear palsy. © 2019 International Parkinson and Movement Disorder Society.
- Published
- 2019
46. A Modified Progressive Supranuclear Palsy Rating Scale
- Author
-
Klaus Seppi, Daniel Macías-García, Meret K. Huber, Lawrence I. Golbe, Yaroslau Compta, Wassilios G. Meissner, Huw R. Morris, Marie Therese Grötsch, Carlo Colosimo, Lea Krey, Maria Stamelou, Milica Jecmenica-Lukic, Joaquim J. Ferreira, Pablo Mir, Gesine Respondek, John C. van Swieten, Günter U. Höglinger, Martin Klietz, Christer Nilsson, Gregor K. Wenning, Johannes Levin, James B. Rowe, Jean-Christophe Corvol, Teodoro Del Ser, Volkswagen Foundation, Munich Cluster for Systems Neurology, Ministry for Science and Culture of Lower Saxony, Petermax Müller Foundation, German Center for Neurodegenerative Diseases, International Parkinson and Movement Disorder Society, Ferreira, Joaquim [0000-0003-3950-5113], Klietz, Martin [0000-0002-3054-9905], Meissner, Wassilios G [0000-0003-2172-7527], Rowe, James B [0000-0001-7216-8679], Stamelou, Maria [0000-0003-1668-9925], Höglinger, Günter U [0000-0001-7587-6187], Apollo - University of Cambridge Repository, Repositório da Universidade de Lisboa, and Neurology
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Movement disorders ,Neurology ,Scale (ratio) ,health care facilities, manpower, and services ,education ,Rating scale ,Severity of Illness Index ,diagnosis [Supranuclear Palsy, Progressive] ,Progressive supranuclear palsy ,03 medical and health sciences ,0302 clinical medicine ,Physical medicine and rehabilitation ,Quality of life ,Clinical meaningfulness ,medicine ,Milestone (project management) ,Humans ,ddc:610 ,health care economics and organizations ,business.industry ,progressive supranuclear palsy ,medicine.disease ,eye diseases ,nervous system diseases ,Clinical trial ,Sensitivity to change ,030104 developmental biology ,sensitivity to change ,Disease Progression ,Quality of Life ,clinical meaningfulness ,Neurology (clinical) ,Supranuclear Palsy, Progressive ,medicine.symptom ,business ,030217 neurology & neurosurgery ,rating scale - Abstract
Describe PSP Study Group, the ProPSP Study Group, and the Movement Disorder Society–Endorsed PSP Study Group., [Background] The Progressive Supranuclear Palsy Rating Scale is a prospectively validated physician-rated measure of disease severity for progressive supranuclear palsy. We hypothesized that, according to experts' opinion, individual scores of items would differ in relevance for patients' quality of life, functionality in daily living, and mortality. Thus, changes in the score may not equate to clinically meaningful changes in the patient's status., [Objective] The aim of this work was to establish a condensed modified version of the scale focusing on meaningful disease milestones., [Methods] Sixteen movement disorders experts evaluated each scale item for its capacity to capture disease milestones (0 = no, 1 = moderate, 2 = severe milestone). Items not capturing severe milestones were eliminated. Remaining items were recalibrated in proportion to milestone severity by collapsing across response categories that yielded identical milestone severity grades. Items with low sensitivity to change were eliminated, based on power calculations using longitudinal 12-month follow-up data from 86 patients with possible or probable progressive supranuclear palsy., [Results] The modified scale retained 14 items (yielding 0–2 points each). The items were rated as functionally relevant to disease milestones with comparable severity. The modified scale was sensitive to change over 6 and 12 months and of similar power for clinical trials of disease-modifying therapy as the original scale (achieving 80% power for two-sample t test to detect a 50% slowing with n = 41 and 25% slowing with n = 159 at 12 months)., [Conclusions] The modified Progressive Supranuclear Palsy Rating Scale may serve as a clinimetrically sound scale to monitor disease progression in clinical trials and routine. © 2021 International Parkinson and Movement Disorder Society., This work was supported by the Munich Cluster for Systems Neurology (Synergy), the Volkswagen Stiftung, the Lower Saxony Ministry for Science, the Niedersächsisches Vorab, and the Petermax-Müller Foundation (Etiology and Therapy of Synucleinopathies and Tauopathies). This project was also supported by the German Center for Neurodegenerative Diseases e.V. (DZNE), German PSP Gesellschaft, and the International Parkinson & Movement Disorder Society.
- Published
- 2021
47. Effects of flood timing on vegetated riparian and coastal habitats in a changing climate
- Author
-
Thorsten Balke, Cai Ladd, Alejandra G. Vovides, Mohammad Basyuni, and Christer Nilsson
- Subjects
Hydrology ,geography ,geography.geographical_feature_category ,Habitat ,Flood myth ,Environmental science ,Riparian zone - Abstract
Ecosystem functioning of habitats at land-water interfaces, such as riparian forests and intertidal salt marshes or mangroves is predominantly driven by inundation. Whereas seasonality of ecological processes (i.e. phenology) and of hydrological extremes/events have been relatively well studied independently from each other their interdependence remains largely unknown. Filling this knowledge gap may become especially important in a changing climate as the timing of ecological and abiotic processes is already changing, often independently from each other. As these ecosystems are increasingly praised as Nature-based Solutions, predicting the ecosystem functioning of riparian forests and coastal wetlands under future climate change is crucial.Here, we will highlight the importance of match and mismatch of ecological and hydrological processes through a range of experiments and field observations in coastal wetlands from the single seedling to the ecosystem level. For riparian floodplains of Europe, we will show how the temporal relationships between flooding and thermal growing season have already changed in past decades, with currently unknown consequences. Finally, we will showcase methodological advances in field monitoring to better study these timing effects and offer conceptual insights to identify tipping points of ecosystem change along land-water interfaces.This presentation will focus on UPH ‘interfaces’ and ‘variability’.
- Published
- 2021
48. Navigating trade-offs between dams and river conservation
- Author
-
Christiane Zarfl, J.P. Carvallo, Bernhard Lehner, J. Hartmann, Christer Nilsson, Günther Grill, M. Goichot, Klement Tockner, Mark Mulligan, Michele Thieme, David Tickner, Jonathan V. Higgins, and Jeffrey J. Opperman
- Subjects
Dam removal ,Oceanografi, hydrologi och vattenresurser ,Management, Monitoring, Policy and Law ,GeneralLiterature_MISCELLANEOUS ,Oceanography, Hydrology and Water Resources ,policies ,ddc:570 ,ddc:550 ,politics and governance ,Environmental planning ,Hydropower ,ddc:910 ,Downstream (petroleum industry) ,planning and design ,Ekologi ,Global and Planetary Change ,ecology and biodiversity ,Ecology ,business.industry ,Energy security ,Climate resilience ,water security ,Miljövetenskap ,ddc ,Current (stream) ,Water security ,Sustainability ,business ,Environmental Sciences ,energy - Abstract
Non-technical summary There has been a long history of conflicts, studies, and debate over how to both protect rivers and develop them sustainably. With a pause in new developments caused by the global pandemic, anticipated further implementation of the Paris Agreement and high-level global climate and biodiversity meetings in 2021, now is an opportune moment to consider the current trajectory of development and policy options for reconciling dams with freshwater system health. Technical summary We calculate potential loss of free-flowing rivers (FFRs) if proposed hydropower projects are built globally. Over 260,000 km of rivers, including Amazon, Congo, Irrawaddy, and Salween mainstem rivers, would lose free-flowing status if all dams were built. We propose a set of tested and proven solutions to navigate trade-offs associated with river conservation and dam development. These solution pathways are framed within the mitigation hierarchy and include (1) avoidance through either formal river protection or through exploration of alternative development options; (2) minimization of impacts through strategic or system-scale planning or re-regulation of downstream flows; (3) restoration of rivers through dam removal; and (4) mitigation of dam impacts through biodiversity offsets that include restoration and protection of FFRs. A series of examples illustrate how avoiding or reducing impacts on rivers is possible – particularly when implemented at a system scale – and can be achieved while maintaining or expanding benefits for climate resilience, water, food, and energy security. Social media summary Policy solutions and development pathways exist to navigate trade-offs to meet climate resilience, water, food, and energy security goals while safeguarding FFRs.
- Published
- 2021
49. The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
- Author
-
Daniel Tesfa, Monika Klimkowska, Jan Palmblad, Henric Lindkvist, Christer Nilsson, Hans Hägglund, Björn E. Wahlin, Birgitta Sander, and Eva Kimby
- Subjects
Male ,Cancer Research ,Late-onset neutropenia ,Neutrophils ,Lymphocyte ,0302 clinical medicine ,Antineoplastic Agents, Immunological ,immune system diseases ,hemic and lymphatic diseases ,B-Cell Activating Factor ,Granulocyte Colony-Stimulating Factor ,Prospective Studies ,APRIL ,Receptors, Immunologic ,CD20 ,Aged, 80 and over ,0303 health sciences ,Hematology ,biology ,Lymphoma, Non-Hodgkin ,General Medicine ,Middle Aged ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,BAFF ,Rituximab ,Female ,SDF1 ,medicine.drug ,Adult ,medicine.medical_specialty ,Neutropenia ,Tumor Necrosis Factor Ligand Superfamily Member 13 ,G-CSF ,03 medical and health sciences ,Internal medicine ,medicine ,Humans ,B-cell activating factor ,030304 developmental biology ,Aged ,Autoantibodies ,Rheumatology and Autoimmunity ,Original Paper ,Reumatologi och inflammation ,Cancer och onkologi ,business.industry ,Autoantibody ,medicine.disease ,Chemokine CXCL12 ,Lymphoma ,Case-Control Studies ,Cancer and Oncology ,Immunology ,biology.protein ,bacteria ,business - Abstract
Mechanisms for late-onset neutropenia (LON) after rituximab treatment are poorly defined both for non-Hodgkin lymphoma (NHL) and for autoimmune disorders. We performed a case–control analysis of a prospective cohort of 169 evaluable consecutive rituximab-treated NHL patients to assess cytokines involved in neutro- and lymphopoiesis (G-CSF, SDF1, BAFF, APRIL) and inflammation (CRP) as possible LON mechanisms. Fifteen patients (9%) developed LON (peripheral blood /PB/ absolute neutrophil counts /ANC/
- Published
- 2021
50. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes
- Author
-
Lianne M. Reus, Bogdan Pasaniuc, Danielle Posthuma, Toni Boltz, Yolande A.L. Pijnenburg, Roel A. Ophoff, Raffaele Ferrari, Dena G. Hernandez, Michael A. Nalls, Jonathan D. Rohrer, Adaikalavan Ramasamy, John B.J. Kwok, Carol Dobson-Stone, William S. Brooks, Peter R. Schofield, Glenda M. Halliday, John R. Hodges, Olivier Piguet, Lauren Bartley, Elizabeth Thompson, Isabel Hernández, Agustín Ruiz, Mercè Boada, Barbara Borroni, Alessandro Padovani, Carlos Cruchaga, Nigel J. Cairns, Luisa Benussi, Giuliano Binetti, Roberta Ghidoni, Gianluigi Forloni, Daniela Galimberti, Chiara Fenoglio, Maria Serpente, Elio Scarpini, Jordi Clarimón, Alberto Lleó, Rafael Blesa, Maria Landqvist Waldö, Karin Nilsson, Christer Nilsson, Ian R.A. Mackenzie, Ging-Yuek R. Hsiung, David M.A. Mann, Jordan Grafman, Christopher M. Morris, Johannes Attems, Timothy D. Griffiths, Ian G. McKeith, Alan J. Thomas, Pietro Pietrini, Edward D. Huey, Eric M. Wassermann, Atik Baborie, Evelyn Jaros, Michael C. Tierney, Pau Pastor, Cristina Razquin, Sara Ortega-Cubero, Elena Alonso, Robert Perneczky, Janine Diehl-Schmid, Panagiotis Alexopoulos, Alexander Kurz, Innocenzo Rainero, Elisa Rubino, Lorenzo Pinessi, Ekaterina Rogaeva, Peter St. George-Hyslop, Giacomina Rossi, Fabrizio Tagliavini, Giorgio Giaccone, James B. Rowe, Johannes C.M. Schlachetzki, James Uphill, John Collinge, Simon Mead, Adrian Danek, Vivianna M. Van Deerlin, Murray Grossman, John Q. Trojanowski, Julie van der Zee, Christine Van Broeckhoven, Stefano F. Cappa, Isabelle Le Ber, Didier Hannequin, Véronique Golfier, Martine Vercelletto, Alexis Brice, Benedetta Nacmias, Sandro Sorbi, Silvia Bagnoli, Irene Piaceri, Jørgen E. Nielsen, Lena E. Hjermind, Matthias Riemenschneider, Manuel Mayhaus, Bernd Ibach, Gilles Gasparoni, Sabrina Pichler, Wei Gu, Martin N. Rossor, Nick C. Fox, Jason D. Warren, Maria Grazia Spillantini, Huw R. Morris, Patrizia Rizzu, Peter Heutink, Julie S. Snowden, Sara Rollinson, Anna Richardson, Alexander Gerhard, Amalia C. Bruni, Raffaele Maletta, Francesca Frangipane, Chiara Cupidi, Livia Bernardi, Maria Anfossi, Maura Gallo, Maria Elena Conidi, Nicoletta Smirne, Rosa Rademakers, Matt Baker, Dennis W. Dickson, Neill R. Graff-Radford, Ronald C. Petersen, David Knopman, Keith A. Josephs, Bradley F. Boeve, Joseph E. Parisi, William W. Seeley, Bruce L. Miller, Anna M. Karydas, Howard Rosen, John C. van Swieten, Elise G.P. Dopper, Harro Seelaar, Philip Scheltens, Giancarlo Logroscino, Rosa Capozzo, Valeria Novelli, Annibale A. Puca, Massimo Franceschi, Alfredo Postiglione, Graziella Milan, Paolo Sorrentino, Mark Kristiansen, Huei-Hsin Chiang, Caroline Graff, Florence Pasquier, Adeline Rollin, Vincent Deramecourt, Florence Lebert, Dimitrios Kapogiannis, Luigi Ferrucci, Stuart Pickering-Brown, Andrew B. Singleton, John Hardy, Parastoo Momeni, Complex Trait Genetics, Amsterdam Neuroscience - Complex Trait Genetics, Child and Adolescent Psychiatry / Psychology, Erasmus MC other, Neurology, Psychiatry, Human genetics, Amsterdam Neuroscience - Compulsivity, Impulsivity & Attention, Amsterdam Reproduction & Development (AR&D), and Amsterdam Neuroscience - Neurodegeneration
- Subjects
0301 basic medicine ,Candidate gene ,17q21.31 inversion region ,Dorsolateral prefrontal cortex ,Expression quantitative trait loci (eQTL) ,Frontotemporal dementia ,SEC22B ,Transcriptome-wide association study ,Semantic dementia ,Gene Expression ,Locus (genetics) ,Biology ,03 medical and health sciences ,0302 clinical medicine ,Progressive nonfluent aphasia ,mental disorders ,medicine ,Humans ,Gene ,Biological Psychiatry ,Genetics ,nutritional and metabolic diseases ,medicine.disease ,Genetic architecture ,nervous system diseases ,030104 developmental biology ,medicine.anatomical_structure ,Frontotemporal Dementia ,030217 neurology & neurosurgery - Abstract
Background: The etiology of frontotemporal dementia (FTD) is poorly understood. To identify genes with predicted expression levels associated with FTD, we integrated summary statistics with external reference gene expression data using a transcriptome-wide association study approach. Methods: FUSION software was used to leverage FTD summary statistics (all FTD: n = 2154 cases, n = 4308 controls; behavioral variant FTD: n = 1337 cases, n = 2754 controls; semantic dementia: n = 308 cases, n = 616 controls; progressive nonfluent aphasia: n = 269 cases, n = 538 controls; FTD with motor neuron disease: n = 200 cases, n = 400 controls) from the International FTD-Genomics Consortium with 53 expression quantitative loci tissue type panels (n = 12,205; 5 consortia). Significance was assessed using a 5% false discovery rate threshold. Results: We identified 73 significant gene–tissue associations for FTD, representing 44 unique genes in 34 tissue types. Most significant findings were derived from dorsolateral prefrontal cortex splicing data (n = 19 genes, 26%). The 17q21.31 inversion locus contained 23 significant associations, representing 6 unique genes. Other top hits included SEC22B (a gene involved in vesicle trafficking), TRGV5, and ZNF302. A single gene finding (RAB38) was observed for behavioral variant FTD. For other clinical subtypes, no significant associations were observed. Conclusions: We identified novel candidate genes (e.g., SEC22B) and previously reported risk regions (e.g., 17q21.31) for FTD. Most significant associations were observed in dorsolateral prefrontal cortex splicing data despite the modest sample size of this reference panel. This suggests that our findings are specific to FTD and are likely to be biologically relevant highlights of genes at different FTD risk loci that are contributing to the disease pathology.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.